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Aflatoxins (AF) are fungal toxic metabolites of Aspergillus flavus and Aspergillus parasiticus, 
which can frequently contaminate a variety of animal feed ingredients. Contamination of poultry 
feed with AF is a major concern to the poultry industry due to their deleterious effects in 
chickens such as reduced chicken performance and increased mortality. Additionally, the 
consumption of AF-contaminated poultry products negatively affects public health due to their 
carcinogenic and hepatotoxic effects. Therefore, it is critical to develop effective strategies for 
controlling AF in poultry feed and aflatoxicosis in chickens. In this Ph.D. dissertation, the 
efficacy of two plant-derived antimicrobials, namely carvacrol (CR) and trans-cinnamaldehyde 
(TC), was investigated for reducing A. flavus and A. parasiticus growth and AF production in a 
broth system and in chicken feed. Moreover, the efficacy of CR and TC for reducing 
aflatoxicosis in chicken embryos and broiler chickens was also studied. Additionally, hepatic 
transcriptome of chickens exposed to AF with or without CR/TC supplementation was 
performed to elucidate the mechanisms behind the protective effects of phytochemicals to 
chickens. Results revealed that CR and TC significantly inhibited growth of AF-producing molds 
and AF production in potato dextrose broth and chicken feed (P < 0.05). Real-time quantitative 
PCR results revealed that CR and TC down-regulated the expression of major genes associated 
with AF biosynthesis (P < 0.05). In addition, CR and TC decreased AF-induced adverse effects 
in chicken embryos by improving the survivability and the weight of chicken embryos when 
exposed to AF (P < 0.05). Moreover, in-feed supplementation of CR and TC ameliorated 
aflatoxicosis in chickens, where phytochemical supplementation significantly decreased relative  
Hsin-Bai Yin – University of Connecticut, 2017 
liver weight, improved relative bursa of Fabricius weight, and reduced AF-induced toxic effects 
in the liver of birds (P < 0.05). Results of the hepatic transcriptome demonstrated that several 
pathways and genes associated with hepatic diseases and lipid metabolism were affected by the 
AF treated diet; however, supplementation of CR and TC to the AF diet modulated genes 
involved in these pathways. Collectively, these results indicate that CR and TC could potentially 
be used as feed additives to control aflatoxicosis in chickens. 
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        Aflatoxins (AF) are a group of toxic metabolites of Aspergillus flavus and 
Aspergillus parasiticus, which can frequently contaminate feed ingredients, including 
peanuts, corn, and cottonseed (Oguz et al., 2000; Sur and Celik, 2003). Contamination 
of poultry feed with AF is a major concern to the poultry industry since aflatoxicosis 
in chickens results in significant economic losses due to poor feed utilization, 
decreased body weight, reduced egg hatchability, and increased mortality (Qureshi et 
al., 1998; Tessari et al., 2006; Oguz, 2011). Since the first outbreak of AF 
contamination that occurred in 1960, the negative effects of AF in poultry have been 
widely investigated (Giambrone et al., 1978; Celik et al., 1996; Sur and Celik, 2003). 
Once ingested by chickens, AF can accumulate in most of the soft tissues and fat 
depots of the chicken resulting in hemorrhagic and enlarged liver (Leeson et al., 1995; 
Bintvihok et al, 2002). In addition, AF residues found in poultry meat and eggs 
(Jacobson and Wiseman, 1974; Sudhakar, 1992; Qureshi et al, 1998) pose a 
significant health hazard to humans due to their carcinogenic, teratogenic, and 
mutagenic properties (Ross et al., 1992; Bintvihok et al., 2002). 
        Among the 16 types of AF identified in feed, AFB1, B2, G1, and G2 constitute 
the major ones (Leeson et al., 1995). Aflatoxin B1 is one of the most potent 
hepatocarcinogens, and its active metabolite, 8, 9, -epoxide, metabolized by P450 
cytochrome in liver, binds to proteins and forms adducts such as AFB1-lysine in 
albumin. Furthermore, this active metabolite binds to guanine residues in DNA 
forming guanyl-N7 adducts, and initiates the formation of hepatocarcinomas (Hsu et 
al., 1991). Due to its carcinogenic properties, AFB1 has been listed as a group I 
human carcinogen by the International Agency for Research on Cancer (Yunus et al., 
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2011).  
        In light of the risks associated with aflatoxicosis in chicken, the U.S. Food and 
Drug Administration (FDA) has established guidelines for the maximum toxin level 
permitted in poultry feed, which is 20 ppb in corn and peanut products for chicks, and 
100 ppb in feed for adult chickens (FDA, 2009). Thus, it is critical to develop 
scientifically validated strategies for controlling AF in poultry feed and aflatoxicosis 
in chickens to protect public health, bird health, and to ensure the economic viability 
of the poultry industry. 
        The overall objective of this dissertation was to investigate the efficacy of two 
natural plant-derived antimicrobials, namely carvacrol (CR) and trans-
cinnamaldehyde (TC), for controlling aflatoxicosis in chickens. The specific 
objectives were: 
1. To study the effect of CR and TC on A. flavus and A. parasiticus growth, 
AF production, and expression of toxin production genes in a broth 
system and in chicken feed during long-term storage. 
2. To determine the efficacy of CR and TC in reducing AF-induced toxicity 
in chicken embryos.  
3. To determine the efficacy of in-feed supplementation of CR and TC in 
reducing aflatoxicosis in chickens. 
4. To investigate the effect of in-feed supplementation of CR and TC on the 
hepatic transcriptome of chicken exposed to AF. 
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1. Production of aflatoxin: Aspergillus flavus and Aspergillus parasiticus  
1.1 Biochemical and physiological characteristics of Aspergillus flavus and 
Aspergillus parasiticus.  
        Fungi are commonly found in a wide range of climate zones, especially between 
latitudes 16o and 35o in warm areas (Klich, 2007). Fungal sclerotia are able to survive 
in soil under severe environmental conditions and produce conidia dispersed by air or 
soil movement, leading to a population increase under hot and drought weather 
conditions (Wicklow et al., 1993; Payne, 1998). Conidia that are distributed through 
air are capable of infecting crops such as maize, tree nuts, peanut seed and cottonseed 
(Horn and Pitt, 1997; Cotty, 2001). Fungal colonization of crops could be enhanced 
with favorable environmental conditions (such as hot and dry) and the damage caused 
by insects and birds (Horn and Pitt, 1997; Payne, 1998). Insect infestations of crops 
such as the lesser cornstalk borer (Elasmopalpus lingosellus Zeller), nitidulid beetles 
(Nitidulid), and rice weevil (Sitophilus zeamais) are associated with enhanced 
infections of Aspergillus spp. (LaPrade and Manwiller, 1977; Lussenhop and 
Wicklow, 1990). 
        Link (1809) first used the name Aspergillus flavus to describe a mold species as 
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well as a group of closely related species. In general, Aspergillus flavus is known as a 
velvety, yellow to green or brown mold with a golden to red-brown reverse (Hedayati 
et al., 2007). Aspergillus flavus isolates can be divided into two phenotypic types 
based on the characteristics of the sclerotia that are produced; the S strain produces 
numerous small sclerotia (average diameter ,400 mm) and the L strain produces fewer 
but larger sclerotia (Cotty, 1989). Raper and Fennell (1965) considered A. flavus 
group to contain nine species and two varieties, including A. flavus, A. flavus var. 
columnaris, A. parasiticus, A. oryzae, A. oryzae var. effusus, A. zonatus, A. clavato-
flavus, A. tamarii, A. flavo-furcatis, A. subolivaceus and A. avenaceus. Aspergillus 
flavus and A.  parasiticus are closely related fungi that are known to contaminate 
numerous crops in the field, during harvest, in storage, and during processing, and can 
grow as unspecialized saprophytes on crop debris in soil (Wicklow and Donahue, 
1984).  
        Susceptibility of crops to A. flavus and A. parasiticus infections varies. For 
example, A. flavus infects a wide range of plant hosts, whereas A. parasiticus is 
generally limited to ground crop hosts due to preferences for the suitable growth 
temperature (Horn et al., 2009). Aspergillus flavus as an opportunistic pathogen of 
 7 
agricultural crops infects oil-containing crops such as maize, peanut, and cottonseed, 
and it is considered to be the dominant species compared to A. parasiticus on maize 
and cottonseed. Aspergillus parasiticus on the other hand, appears to be adapted to a 
soil environment, so it is prominent in peanuts (Horn et al., 1998).  
1.2 Aflatoxin production 
        Mycotoxins are fungal secondary metabolites that are harmful to the health and 
development of animals or humans. The first outbreak of aflatoxin poisoning was 
reported in turkeys, which was identified as Turkey “X” disease in England in 1960s 
causing the death of 100,000 turkeys (Blount, 1961; Van der Zijden, 1962). The 
Turkey “X” disease led to the discovery of aflatoxin from the groundnut meal 
contaminated by A. flavus (Hesseltine, 1979), and the term “aflatoxin” came from 
“Aspergillus flavus toxin” (Yu et al., 2004). Among the 16 different types of aflatoxins, 
aflatoxin B1, B2, G1, and G2 are the major toxins that contaminate crops (Goldblatt, 
1969). Aflatoxin B1 (AFB1) is one of the most potent hepatocarcinogens, and its 
active metabolite, 8, 9, -epoxide, metabolized by cytochrome P450 (CYP450) in liver, 
binds to proteins and forms adducts such as AFB1-lysine in albumin. Furthermore, 
this active metabolite binds to guanine residues in DNA forming guanyl-N7 adducts, 
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and initiates the formation of hepatocarcinomas (Hsu et al., 1991). Due to its 
carcinogenic properties, AFB1 has been listed as a group I human carcinogen by the 
International Agency for Research on Cancer (Yunus et al., 2011). 
        As described previously, based on the size of the sclerotia, A. flavus can be 
characterized into L strains (sclerotia > 400 mm) and S strains (sclerotia < 400 mm), 
and it has been confirmed that both A. flavus S and L strains produce aflatoxins B1 
and B2, but A. flavus S strains and A. parasiticus may also produce aflatoxins G1 and 
G2 (Cotty, 1989, Yu, 2004; Horn et al., 2003). Other than aflatoxins, A. flavus is able 
to produce toxins such as sterigmatocystin, cyclopiazonic acid, kojic acid, and beta-
nitropropionic acid. 
        In general, warm and humid conditions (30°C and water activity of 0.99) at pre-
harvest and post-harvest levels, and during transport or storage time, promote 
toxigenic Aspergillus spp. colonization, followed by aflatoxin production and 
accumulation in crops and feedstuff (Cotty and Jaime-Garcia, 2007; Rawal et al., 
2010). In addition, proper substrates, incubation time, and CO2 levels may also affect 
the production of aflatoxins (Schindler et al., 1967; Schroeder et al., 1967; Trenk et al., 
1970; Gqaleni et al., 1997; Medina et al., 2014). Once food-producing animals ingest 
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aflatoxin-contaminated feed, aflatoxin residues can be transferred to milk, meat and 
eggs of livestock and poultry (CAST, 2003; Pandey and Chauhan, 2007; Aly and 
Anwer, 2009). Hence, aflatoxin contamination is considered as a human food safety 
risk in both plant and animal products. Although aflatoxin contamination happens at 
both pre- and post-harvest levels, post-harvest aflatoxin contamination of seeds is the 
major problem because of improper storage practices, primarily under excessive 
moisture, and insect activity (Cotty, 1997). 
        Aflatoxins, as secondary metabolites of molds have a very complicated 
biosynthesis pathway, which involves a cluster of at least 29 genes in a contiguous 75 
kb region, and more than 23 enzymatic reactions are required to synthesize AF (Yu et 
al., 2004, Ehrlish et al., 2005). In the aflatoxin biosynthesis pathway, aflC, nor1, norA 
and ver1 are the principal genes related to aflatoxin production, where aflC involved 
in the conversion of acetate to norsolorinic acid (NOR) plays a critical role in early 
aflatoxin biosynthesis pathway. Ehrlich and Cotty (2004) reported that nonsense 
mutation of this gene resulted in the loss of aflatoxin synthesis in molds. Similarly, 
nor1 and norA are involved in the conversion of NOR to averatin (AVN), where NOR 
is the key structural intermediate in the pathway (Bennett, 1981). Moreover, nor1 has 
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been used as a potential marker gene to discriminate between toxigenic or 
nontoxigenic strains (Mayer et al., 2003). ver1 encodes an enzyme that converts 
versicolorin (VERA) to demethyl-sterigmatocyin (DMST), which is located in the last 
step of aflatoxin biosynthesis pathway before the intermediates start differentiating 
into different types of aflatoxins (AFB1, B2, G1, and G2). 
1.3 Economic importance  
        Aspergillus flavus colonization does not necessarily reduce the yield of affected 
crops, but causes economic losses due to aflatoxin contamination. Worldwide, 
aflatoxins are considered a major public health problem, especially in developing 
countries, where long-term food storage is often inadequate for high heat and 
humidity, which encourage mold growth (Eaton and Gallagher, 1994). The economic 
impacts attributed to aflatoxin are incurred directly by losses in crops, livestock, and 
dairy, and indirectly by a recurring expenditure in quality-control programs, research 
and education, lower foreign exchange earnings, and increased storage and packaging 
costs of vulnerable commodities (Mishra and Das, 2003). Mycotoxin contamination 
in agriculture has caused an estimated average economic loss at approximately one 
billion dollars per year in the United States (Vardon et al., 2003), and among all the 
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mycotoxins, aflatoxin contamination is the most serious one worldwide (CAST, 2003). 
According to Rubens and Cardwell’s report, aflatoxin contamination resulted in an 
annual economic loss of approximately $25 million on peanut in the state of Georgia, 
$2-15 million losses on maize in Texas, Mississippi, and Arizona, $3.8 million on 
walnuts in California, and $2.3-4.7 million in California (Rubens and Cardwell, 2005). 
Although dollar losses are not available from developing countries in Asia and Africa, 
the losses in these countries are considered to be more severe than in the United States 
(Yu et al., 2005). In an effort to control aflatoxin exposure to animals and humans, the 
US Food and Drug Administration (FDA) has set a limit of 20 ppb of aflatoxin in 
food for human consumption, 100 ppb for animal consumption, and 0.5 ppb in milk 
(Georgianna and Payne, 2009). 
2. Etiology of Aflatoxins  
        In the early 1960s, Turkey “X” Disease, which was characterized as an outbreak 
of hepatotoxic disease, led to the discovery of aflatoxins (Asplin and Carnaghan, 1961; 
Eaton and Gallagher, 1994). Soon after the outbreak of Turkey “X” disease, 
researchers discovered that aflatoxin contamination was responsible for another 
outbreak of hepatocellular carcinomas in hatchery-reared rainbow trout, a species for 
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which background tumor rates were very low (Halver, 1969). Since the discovery of 
the aflatoxins, researcheres have been intensively studying their toxicity, 
carcinogenicity, mutagenicity, and teratogenicity to humans and animals under 
different conditions such as sex, age, nutritional status, and the effect of chemicals 
(Ellis et al., 1991).  
2.1 Biotransformation of aflatoxin in liver 
        Once AFB1 enters the host, it is first absorbed in the small intestine, especially 
the duodenum (Gratz et al., 2005). However, because enzymes present in the small 
intestine have a low affinity for AFB1 (Guengerich et al., 1996), the majority of the 
absorbed aflatoxins is metabolized in the liver, where AFB1 initiates its 
carcinogenicity through bio-activation (Eaton and Gallagher, 1994), including four 
reactions: (1) O-demethylation, (2) hydroxylation, (3) epoxidation, and (4) 
ketoreduction (Massey et al., 1995). During the biotransformation of AFB1 in liver, 
AFB1 becomes an intermediate form, AFB1-8,9-epoxide (AFBO), and then exerts its 
hepatocarcinogenic effects by binding with DNA, RNA, and proteins in the liver 
(Eaton and Gallagher, 1994; Leeson et al., 1995; Bedard et al., 2006).  
2.1.1 Hydroxylation and O-demethylation of AFB1 
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        When AFB1 reaches liver, it can be oxidized to its hydroxylated metabolites, 
including AFM1, AFP1, and AFQ1 by the microsomal cytochrome P450-dependent 
monooxygenases. For example, AFQ1 is formed via 3a hydroxylation of AFB1, 
whereas AFM1 is produced by 9a hydroxylation of AFBl, and AFP1 is formed 
through an O-demethylation of AFB1. In general, toxicities of these hydroxylated 
metabolites are lower than their parent compound (Hsieh et al., 1974). For instance, 
AFMl isolated and identified as an AFBl metabolite in milk is approximately 30% as 
carcinogenic as AFB1 in trout (Holzapfel and Steyn, 1966; Sinnhuber et al, 1974), 
and approximately 10% as carcinogenic in rats (Hsieh et al., 1984). Similarly, it has 
been shown that AFQ1 only exhibits approximately 1% of the toxicity of AFB1 in 
rainbow trout (Hendricks et al., 1980).  
        In animals, the O-demethylation of AFB1 produces AFP1 (Wong and Hsieh, 
1980). Kirby et al. (1994) observed an increase in AFP1 concentrations in the liver 
from the patients with diagnosed liver tumors when compared to the normal liver 
tissue. Moreover, AFP1 was also highly correlated to all urinary AFB1 metabolites in 
humans with liver cancer (Ross et al., 1992).  
2.1.2 Epoxidation of AFB1 
 14 
        Microsomal cytochrome P450 (CYP450)-dependent epoxidation of the terminal 
furan ring of AFB1 results in the formation of AFBO, which can be disrupted by 
interception with trapping agents such as DNA, and also with glutathione (GSH) and 
glutathione S-transferases (GSTs). AFBO may be conjugated enzymatically with GSH, 
which serves as a critical pathway for AFB1 detoxification (Eaton and Gallagher, 
1994). Therefore, the ratio of AFB1 epoxidation and GSH conjugation affects the 
amount of AFB1-DNA adduct formation. For both chemical and enzymatic reactions, 
epoxidation of AFB1 results in the formation of endo AFB1-8,9-epoxide or exo 
AFB1-8,9-epoxide (Raney et al., 1992; Eaton and Groopman, 1994). The exo-epoxide 
is the isomer implicated in the alkylation of DNA, with its reactivity being at least 
1,000 fold greater than that of the endo-epoxide (Lyer et al., 1994). Therefore, exo-
epoxide is more likely to form AFB1-DNA adducts and it is considered to be more 
mutagenic than the endo-epoxide.  
        Several researches confirmed the involvement of CYP450 enzymes in the AFB1 
bio-activation, including members of 1A, 2B, 2C, and 3A subfamilies in experimental 
animals (Yoshizawa et al., 1982). In humans, multiple CYPs are involved in AFB1 
biotransformation, including CYP1A2, CYP2A3, CYP2B7, CYP3A3, CYP3A4, and 
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CYP2A13 (Shimada and Guengerich, 1989; Massey et al., 1995). Human CYP3A4 is 
activated at high AFB1 concentrations, while CYP1A2 has a high affinity at lower 
concentrations (Ramsdell et al., 1991; Gallagher et al., 1994). The rate of AFBO 
formation also varies in different species based on the activity of the CYP450 
enzymes, for example, human CYP450 enzymes produce only approximately of 25% 
AFBO than that in rats (Ramsdell and Eaton, 1990). 
        Although CYP450 enzymes are responsible for a majority of the AFB1 
epoxidation, other enzymes such as prostaglandin H synthase (PHS), lipoxygenases 
(LOX), and a cytosolic NADPH-dependent reductase can also activate AFB1 
epoxidation through CYP450-independent pathways (Battista and Marnett, 1985; Liu 
and Massey, 1992; Massey et al., 1995). Battista and Mamett (1985) reported that 
PHS-dependent epoxidation of AFB1 can co-occur with CYP450-mediated AFB1 
epoxidation. Also, LOX from liver and kidney can activate AFB1 to DNA-bound 
derivatives (Liu and Massey, 1992). Furthermore, the kinetics of LOX-dependent 
hepatic DNA binding suggests that this pathway could be particularly active at dietary 
levels of AFB1 exposure (Liu and Massey, 1992).  
2.1.3. Ketoreduction of AFB1 
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        Ketoreduction of AFB1 results in the formation of aflatoxicol by reduction of the 
1-keto-group through a cytosolic NADPH-dependent reductase (Salhab and Edwards, 
1977; Woloshuk and Prieto, 1998; Dohnal et al., 2014). Aflatoxicol can be further 
metabolized to aflatoxicol-M1 (Loveland et al., 1988). Aflatoxicol has been reported 
to be a potent mutagen, and is approximately 50% as carcinogenic as AFB1 and 70% 
as mutagenic as AFB1 in trout (Schoenhard et al., 1981; Coulombe et al., 1982; 
Ottinger et al., 2000). Aflatoxicol can also be rapidly reversed to AFB1 by 
dehydrogenase, thereby increasing the physiological half-life of AFB1 (Salhab and 
Edwards, 1977; Woloshuk and Prieto, 1998; Dohnal et al., 2014). Liver from species 
that are sensitive to AFB1 typically exhibits high ratios of AFB1 reductase versus 
aflatoxicol dehydrogenase activities than the less sensitive species such as rodents 
(Salhab and Edwards, 1977; Woloshuk and Prieto, 1998; Dohnal et al., 2014).  
3. Aflatoxicosis in humans 
        Numerous epidemiological studies of human populations exposed naturally to 
aflatoxin-contaminated foods have been reviewed extensively. Aflatoxicosis in 
humans can be characterized into acute and chronic conditions based on the 
concentration of consumed aflatoxins and the period of time that the hosts are 
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exposed to the toxin (Williams et al., 2004). Acute aflatoxicosis, resulting from 
consuming a high-concentration of aflatoxin over a short period of time, often results 
in outbreaks in humans. For example, Kenya experienced the most serious recent 
outbreak of aflatoxin contamination in 2004 with 317 cases and 125 reported deaths 
(Azziz-Baumgartner et al., 2005). Low-dose aflatoxin consumption over an extended 
exposure time results in chronic aflatoxicosis, which can cause in immune 
suppression, stunting, and liver cancer in humans. Approximately 4.5 billion people 
are at risk of chronic exposure to aflatoxin-contaminated food (Hamid et al., 2013).  
        Several epidemiological studies have supported the correlation between the 
dietary aflatoxin intake and the incidence of human hepatocellular carcinoma, where 
AFB1 is the most hepatocarcinogenic mycotoxin and the main contributor to the high 
rate of hepatocellular carcinoma (Hamid et al., 2013). One of the mechanisms of 
aflatoxin-induced liver cancer is from a mutation in the tumor suppressor gene, p53, 
in the liver (Hsu et al., 1991). The rate of hepatocellular carcinoma was found to be 
increased by at least 30-fold in the presence of both aflatoxin and the hepatitis B or C 
virus infection, creating severe health problems for people living in developing 
countries, where both aflatoxin and hepatitis viruses are common (Kuang et al., 2005; 
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Groopman et al., 2008). Similarly, Ross et al. (1992) analyzed over 18,000 urine 
samples for the presence of the N7-guanine adduct of aflatoxin. In their study, 22 
urine samples from the subjects who developed liver cancer during the analysis, were 
examined for the presence of hepatitis B virus surface antigen and aflatoxin exposure 
biomarker. Results revealed that aflatoxin exposure alone (hepatitis B antigen-
negative) yielded a relative risk of about two; hepatitis B virus antigen positive status 
alone (aflatoxin exposure negative) yielded a relative risk of about five. However, 
combined exposure (aflatoxin plus hepatitis B virus positive antigen) yielded a 
relative risk of over 60 (Ross et al., 1992). 
        In order to assess chronic aflatoxin exposure, studies have focused on the 
development of accurate and applicable biomarkers of exposure to aflatoxin such as 
aflatoxin-related urinary metabolites due to dietary aflatoxin intake (Groopman et al., 
1988; Groopman et al., 1992; Qian et al., 1994). Zhu et al. (1987) conducted a study 
in China and found a high correlation score of 0.65 between total dietary AFB1 intake 
and urinary AFM1 excretion in 32 households in the Guangxi region. Similarly, Wild 
and co-workers (1992) found a high correlation between dietary intake and urinary 
excretion of aflatoxin metabolites; AFB1-N7-guanine adduct in urine represented the 
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most reliable urinary biomarker of aflatoxin exposure (Groopman 1988; Qian et al., 
1994). Albumin-lysine-AFB1 adduct is another biomarker of aflatoxin exposure; Hall 
and Wild (1994) found a 10-fold fluctuation in urinary aflatoxin metabolites over a 4-
day period and ~ 2-fold fluctuation in albumin-AFB adducts in the same period. In 
addition, in the same case-control study which investigated the relationship between 
aflatoxin and liver cancer in China, albumin-AFB1 adduct concentration in peripheral 
blood was correlated with individual dietary aflatoxin intake (Hall and Wild, 1994).  
4. Aflatoxicosis in poultry   
        Studies conducted during the last five decades have investigated the negative 
effects of aflatoxins on various farm animals, including effects on animal 
performance and metabolism, metabolism of the toxin, and carryover of toxic residues 
in animal products (Diaz, 2005). Animal susceptibility to the acute effects of 
aflatoxicosis varies widely. The LD50 (mg/kg body weight) of AFB1 is 0.3 for 
ducklings, and 6.0 for chickens. The variation in the sensitivity of various animal 
species towards AFB1 is believed to be linked with differences in the toxin’s 
metabolism and the types of metabolites formed (Emafo, 1976). In general, domestic 
turkeys (Meleagris gallopavo) and ducks (Anas platyrhynchos) are more sensitive to 
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both the acute and chronic toxicity of AFB1 than chickens (Gallus gallus) except 
during embryonic development (Giambrone et al., 1985; Klein et al., 2000; Rawal et 
al., 2010). During chicken embryonic development, a LD50 dose of AFB1 to chicken 
embryo could be as low as 0.3 mg/kg body weight (Cullen and Newberne, 1993; 
Leeson et al., 1995). Even when toxin exposure does not cause mortality or morbidity, 
aflatoxicosis contributes directly and indirectly to losses in the poultry industry. 
4.1 Economic impact of aflatoxicosis in poultry  
        The Food and Agriculture Organization (FAO) reported that 25% of the world’s 
grains are contaminated by mycotoxins, and aflatoxin contamination is the most 
common among them. The economic losses due to aflatoxin contamination to the US 
poultry industry exceeded $143 million annually (CAST, 1989). Aflatoxicosis in 
poultry resulting from the ingestion of aflatoxin contaminated feed negatively affects 
production values, causing severe economic losses to the poultry industry. Dietary 
exposure to aflatoxins leads to a decrease in performance, including decreased body 
weight gain and absolute body weight in both chickens and turkeys (Giambrone et al., 
1985; Quezada et al., 2000; Pandey and Chauhan, 2007). In addition, aflatoxicosis 
reduces feed intake and decreased efficiency of nutrient usage, which increases the 
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feed conversion ratio causing poultry to require more feed to produce meat and eggs 
(Verma et al., 2004; Yarru et al., 2009; Lee et al., 2012). For example, Dersjant-Li 
and coworkers (2003) reported that each mg of AFB1/kg diet would decrease the 
growth performance of broilers by 5%. Similarly, Miazzo et al. (2000) found a 
reduction of 11% in body weight gain when 2.5 mg AFB1/kg diet was fed to broilers 
from 21 to 42 days of age as compared to birds fed a diet devoid of aflatoxin 
contamination. Aflatoxicosis also affects the reproductive performance of poultry. 
When layer hens were fed AFB1 in their diet, age to maturity was increased and egg 
production decreased (Azzam and Gabal et al., 1998; Garlich et al., 1973; Howarth et 
al., 1976; Khan et al. 2014).  
4.2 Hepatotoxicity of aflatoxin in poultry  
        It is well known that the liver is the primary organ of aflatoxin bio-activation and 
detoxification (Giambrone et al., 1985; Klein et al., 2000; Rawal et al., 2010). Micco 
and colleagues (1988) reported that when chickens were exposed to an aflatoxin 
contaminated diet, AFB1, AFM1, and aflatoxicol were detected in liver, kidneys, and 
thigh muscles. Longer exposure to aflatoxin contaminated feed leads to an increase in 
the relative weight of liver and causes pale or yellowed pigmentation in poultry 
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(Verma et al., 2004; Yarru et al., 2009; Lee et al., 2012). At the cellular level, 
increased vacuolation of AFB1-exposed hepatocytes allows high levels of lipids to 
accumulate (Sims et al., 1970; Giambrone et al., 1985; Oliveira et al., 2002). Steatosis 
is therefore responsible for the changes in liver color and size during aflatoxicosis. 
Recent studies have shown that CYP2A6 and to a lesser extent CYP1A1 are 
responsible for the bio-activation of AFB1 into the epoxide form in the liver of 
chickens and quail (Diaz et al., 2010). 
        Modern broilers are known to gain more weight by utilizing less feed in a shorter 
time (Qureshi and Havenstein, 1994; Dozier et al., 2008). Because of the 
hepatotoxicity of AFB1, it might result in more profound negative effects in birds 
with more efficient nutrient conversion demanding faster hepatic metabolism. Both 
acute and chronic aflatoxicosis in poultry cause AFB1-induced liver damage, 
including focal necrotic hepatocytes or hemorrhages (Newberne and Butler, 1969; 
Giambrone et al., 1985; Klein et al., 2002). Acute damage initiates inflammatory 
responses and results in leukocyte infiltration and proliferation in the liver (Cova et al., 
1990). Additionally, short-term exposure to high doses of aflatoxin causes morbidity 
and mortality due to extensive liver damage (Rawal et al., 2010). In poultry, chronic 
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AFB1 consumption is mutagenic and causes remodeling of liver tissues. Hyperplasia 
of bile duct epithelial cells or development of oval cells, followed by periportal 
fibrosis and nodular tissue regeneration have been reported (Cova et al., 1990; 
Ortatatli and Oguz, 2001).  
        AFB1 forms adducts with biomolecules causing damage to hepatocytes that 
impairs metabolic functions of the liver. As the liver is responsible for the production 
of most circulating proteins (Rauber et al., 2007), aflatoxicosis reduces the 
concentrations of albumin, globulin, cholesterol, and triglyceride levels in serum, 
whereas AFB1 at levels of 1 mg/kg decreases the total serum protein and albumin 
contents (Quezada et al., 2000; Siloto et al., 2013). In addition, AFB1 also diminishes 
the levels of multiple blood coagulation factors that are produced in the liver of 
chickens and turkeys (Witlock and Wyatt, 1981; Fernandez et al., 1995). Protein 
content likely declines because AFB1-DNA adducts inhibit transcription or 
translation and AFB1-lysine adducts result in protein degradation or excretion. 
4.3 Embryotoxicity of aflatoxins in poultry  
        AFB1 and its metabolites can be transferred from the laying hen into the albumin 
and yolk of the egg (Oliveira et al., 2000; Oliveira et al., 2003). Signs of aflatoxicosis 
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in chicks and poults have been noted if they are exposed to AFB1 during development 
(Khan et al., 2014). Transfer of aflatoxins into embryonated eggs is a concern for 
poultry producers, because many studies with in ovo AFB1 injections confirmed the 
risk of AFB1 exposure to embryos. For example, in ovo exposure of chickens and 
turkeys to AFB1 caused DNA damage in the embryonic liver and increased embryo 
mortality (Dietert et al., 1985; Edrington et al., 1995; Celik et al., 2000; Sur et al., 
2003; Williams et al., 2011; Oznurlu et al., 2012). When laying hens were fed with 
AFB1 contaminated feed to simulate the natural route of embryonic exposure, AFB1 
caused reduced hatchability (Howarth et al., 1976; Qureshi et al., 1998; Khan et al., 
2014) and compromised cellular and humoral immune functions post hatch (Sur et al., 
2011; UI-Hassan et al., 2012). Embryonic AFB1 exposure can lead to morphological 
defects (Edrington et al., 1995) such as abnormal area opaca cells (Celik et al., 2000; 
Sur et al., 2003), skeletal defects in the tibia growth plate (Oznurlu et al., 2012), and 
inhibition of bursal follicle development (Celik et al., 2000; Sur et al., 2003), which 
can consequently reduce embryo viability and adversely affect hatched progeny. In 
addition, embryonic exposure of AFB1 causes immunosuppression, thereby 
increasing the incidence of infectious disease in young poultry and detrimentally 
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affecting their health and productivity. 
5. Strategies to control aflatoxins 
        Because of the recognition of aflatoxin as a potent human carcinogen, federal 
regulation of allowable amounts of the toxin in food and feed is nearly universal. The 
Food and Drug Administration (FDA) in the United States regulates the amount of 
allowable aflatoxin contamination as 20 ppb in crops or 0.5 ppb in milk for humans. 
In Europe, foods containing more than 2 ppb of AFB1 or 4 ppb of aflatoxins are 
rejected, whereas the limit of aflatoxin contamination is 30 ppb in India (Van Egmond 
and Jonker, 2005). 
        Extensive studies have been conducted for controlling aflatoxin contamination 
(Goldblatt, 1969, 1971; Pons and Goldblatt 1969; Pons 1976) since the discovery of 
this toxin. In principle, there are three possible ways to avoid harmful effects caused 
by aflatoxin: (1) prevention of aflatoxin producing fungi at pre-harvest stage; (2) 
detoxification of aflatoxin-contaminated food and agricultural commodities at post-
harvest level; (3) inhibition of absorption of aflatoxin from consumed food in the 
digestive tract to reduce aflatoxicosis 
5.1 Pre-harvest control strategies  
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        One strategy to control aflatoxin contamination at the pre-harvest level is based 
on the identification of crop lines resistant to insects or harsh environmental 
conditions such as drought, because insects and drought stress damage crops, thereby 
favoring aflatoxin contamination (Campbell et al., 1995; Campbell et al., 1997; Lynch 
et al., 2003; Cotty and Jaime-Garcia, 2007). Several researchers have focused on 
identifying fungus-related and aflatoxin-resistant genes and proteins that are 
important for defense against A. flavus invasion and/or aflatoxin bio-synthesis (Huang 
et al., 1997; Chen et al., 2006; Guo et al., 2006; Chen et al., 2010). Therefore, genetic 
modifications of crops such as corn, cottonseed, and peanut may gain resistance to 
aflatoxin contamination by being transferred with the genes that are responsible for 
aflatoxin inhibition enzymes (Cary et al., 2000, Mishra and Das, 2003). In addition, 
control of aflatoxin can also be achieved by targeting mechanisms governing aflatoxin 
bio-synthesis with the identification of genes and enzymes responsible for aflatoxin 
synthesis (Yu et al., 2000; Chang et al., 2000). Moreover, many organisms such as 
bacteria, molds, and algae can degrade or reduce aflatoxin (Mishra and Das, 2003). 
For example, utilization of non-aflatoxigenic A. flavus strains (or called atoxigenic 
strains; strains that cannot produce aflatoxin) as a bio-control agent to inhibit the 
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growth of aflatoxigenic A. flavus in the field has been investigated. Mechanism of this 
bio-control is through competitive exclusion or inhibition of toxigenic A. flavus by 
non-toxigenic strains for nutrient substrates (Cleveland et al., 2003; Pitt and Hocking, 
2006). Large-scale development of atoxigenic strains has been undertaken since 1998 
by the Arizona cotton industry (Antilla and Cotty, 2001). To ensure the effectiveness 
of atoxigenic A. flavus strains to control aflatoxin contamination on crops, they must 
be applied at a time and in a manner that allows successful competition with 
aflatoxin-producers (Cotty et al., 1994). This means atoxigenic strains should be 
applied when the aflatoxin concentrations on the crops are still comparatively low 
(Cotty et al., 1994; Cotty, 1997). Two biological control agents using non-toxigenic A. 
flavus strains registered by the U.S. Environmental Protection Agency are currently 
commercially available. Afla-Guard is one of the agents that is composed of hulled 
barley coated with conidia of non-toxigenic A. flavus strain NRRL21882, which is 
registered for use on peanuts and corn (Dorner, 2010). The other bio-control agent is 
A. flavus AF36, primarily used for reducing aflatoxin on cottonseed. Here, A. flavus 
strain NRRL21882 lacks the aflatoxin bio-synthesis cluster from hexA to the 
telomeric region, and AF36 is defective in the aflatoxin polyketide gene pksA. Thus, 
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both stains are not able to produce aflatoxins (Ehrlich and Cotty, 2004). Similarly, 
small-scale experiments have also been conducted on competitive exclusion using 
Bacillus thuringiensis, the bacterium that produces Bacillus thuringiensis toxins (BT). 
Bacillus thuringiensis has not only been assessed for biological control properties 
against insects for decades, but also been studied for its antifungal effects on fungal 
colonization and mycotoxin contamination (Zhakharian et al., 1979). However, results 
were not consistent in terms of the efficacy on transgenic BT corn in reducing 
aflatoxin contamination. For example, Abbas et al. (2008) documented that aflatoxin 
contamination has been reduced in BT corn when compared with a non-BT line, 
whereas Buntin et al. showed no significant differences between non-BT and BT corn 
(Buntin et al., 2001). Scientific reports have indicated that tremendous reduction of 
aflatoxin levels in BT maize can occur when high levels of insect resistance are 
available (Cleveland et al., 2003).  
5.2 Post-harvest control strategies 
        After harvest, crops can still be contaminated by aflatoxin-producing fungus and 
aflatoxin, if the crops are improperly treated during drying process, and stored under 
poor conditions such as excessive heat and moisture, and exposure to insects and 
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other pests (Hell et al. 2000). Hence, controlling aflatoxin in post-harvest settings is 
crucial. For a detoxification method to be acceptable, it must be efficient, safe and 
cost effective while safeguarding nutritional quality (Hell et al., 2008). There are 
several physical methods for detoxification of aflatoxin at post-harvest level such as 
prolonged heating with pressure; however, certain nutrients could be destroyed during 
the process. In addition, a variety of chemicals have also been screened for their 
ability to react with aflatoxins such as methanol, oxidizing agents, and ammonia 
(Samarajeewa et al., 1990). Some mycotoxins can be destroyed chemically with 
calcium hydroxide, monoethylamine, ozone or ammonia, where ammoniation 
degrades 95-98% of the aflatoxin. However, public health safety concerns of chemical 
residues have limited their applicability in foods. 
        Another post-harvest intervention is to use microorganisms for degradation of 
aflatoxin in food or animal feed. Karunaratne (1990) indicated that Lactobacillus 
acidophilus, Lactobacillus bulgaricus, and Lactobacillus planatarum could be used to 
inhibit the growth of the aflatoxin-producing molds and degrade aflatoxin. 
Bifidobacterium is also reported to bind to AFB1 efficiently to reduce aflatoxin 
(Peltonen et al., 2000). However, using probiotic bacteria to reduce aflatoxin 
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contamination also has its disadvantages since these microorganisms would not only 
utilize the food for their growth, but may themselves release undesirable compounds 
such as organic acids.  
        Several interventions have been developed to control aflatoxin contamination in 
feed to reduce aflatoxicosis in animals and subsequent transfer of aflatoxin residues 
from food-producing animals to humans. To minimize the considerable economic 
losses caused by aflatoxin contaminated crops (Henry et al., 1999), various non-
nutritive adsorbents have been employed for reducing or inactivating aflatoxin in 
feeds. For instance, supplementation of a toxin binder such as clay in the feed is one 
of the widely used approaches to control aflatoxin in the feed industry. The clay 
selectively binds tightly to aflatoxins to prevent their absorption in the gastrointestinal 
tracts and the clay-aflatoxin complex is eliminated from the body (Hell et al., 2008). 
Evidence suggests that aflatoxins may react at multiple sites on the clay particle, 
especially interlayer regions, edges, and basal surfaces (Mishra and Das, 2003). 
Hydrated sodium calcium aluminosilicates (HSCAS) is another toxin binder, which 
reduces aflatoxin absorption by binding with the β-carbonyl portion of aflatoxin 
molecules, thereby effectively reducing aflatoxicosis (Scheideler, 1993; Ledoux et al., 
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1999). Hydrated sodium calcium aluminosilicates (HSCAS) have also been 
demonstrated to act as an aflatoxin enterosorbent that tightly and selectively binds the 
toxin in the gastrointestinal tract of animals, thus decreasing their bioavailability and 
consequently alleviating aflatoxicosis (Scheideler, 1993; Phillips, 1999). Such 
adsorbents act more as prophylactics than curative remedies. However, there may be 
certain risk factors for their inclusion in diet before proper testing, since several 
adsorbents have been shown to impair nutrient utilization (Kubena et al., 1993) and 
mineral absorption in animals (Edrington et al., 1997). 
6. Phytochemicals 
        Plant-derived essential oils are a group of natural and environmentally friendly 
antimicrobials that have traditionally been used as food preservatives and flavor 
enhancers (Pitasawat et al., 2007; Upadhyay et al., 2014). A great majority of these 
compounds are secondary metabolites, and are produced as a result of reciprocal 
interactions between plants, microbes, and animals (Reichling, 2010). These 
secondary metabolites could be species or genera specific in their action, and do not 
primarily contribute to major metabolic processes in plants, but potentiate their ability 
to survive local environments (Harborne, 1993) and defend plants against 
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microorganisms such as bacteria, fungi and viruses (Kennedy and Wightman, 2011). 
In the past decade, the use of plant-derived compounds has gained significant 
attention due to increasing concerns over the safety of synthetic chemicals and the 
emergence of antibiotic-resistant strains of microorganisms (Salamci et al., 2007). The 
antifungal and antitoxigenic properties of several plant oils have been identified (Burt 
et al, 2004). The plant-derived antimicrobials investigated for controlling aflatoxicosis 
in this Ph.D. dissertation research were carvacrol (CR) and trans-cinnamaldehyde 
(TC). 
6.1 Carvacrol 
        Carvacrol (CR), listed as generally recognized as safe (GRAS) by the FDA, is a 
major component in oregano oil obtained from Origanum vulgare (Lamiaceae), a 
common herb found in Europe and the Mediterranean. Oregano oil has been found 
effective against bacterial and fungal infections of the gastrointestinal and 
genitourinary tract (Blumenthal et al., 2000; Adam et al., 2004; Chun et al., 2005) as 
well as against a wide range of bacterial pathogens, including Staphylococcus aureus, 
Escherichia coli, and Streptococcus pneumoniae (Hersch-Martinez et al., 2005). In 
addition, oregano oil was found to inhibit the growth of Fusarium proliferatum and 
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fumonisin B1 production in maize (Velluti et al., 2003). 
6.2 Trans-cinnamaldehyde 
        Trans-cinnamaldehyde (TC) is another GRAS-status ingredient present in the 
bark extract of cinnamon (Cinnamomum zeylandicum). Various studies have 
demonstrated the antimicrobial properties of TC against both gram-negative and -
positive bacteria (Burt, 2004; Gill and Holley, 2006; Upadhyay et al., 2014). Previous 
research from our laboratory found that TC was effective in inhibiting biofilm 
formation and inactivating mature biofilms of Cronobacter sakazakii (Amalaradjou 
and Venkitanarayanan, 2011) and uropathogenic Escherichia coli (Amalaradjou et al., 
2010). Additionally, our laboratory investigated the efficacy of TC in reducing 
Salmonella Enteritidis colonization in chickens (Kollanoor-Johny et al., 2012). The 
results from this study showed that in-feed supplementation of TC to chickens did not 
adversely affect the chicken’s performance and feed palatability (Kollanoor-Johny et 
al., 2012). 
        In summary, aflatoxins are fungal toxic metabolites of A. flavus and A. 
parasiticus, which can frequently contaminate a variety of feed ingredients. 
Contamination of poultry feed with aflatoxins is a major concern to both feed and 
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poultry industry due to their deleterious effects in chickens such as reduced chicken 
performance and increased mortality. In addition, aflatoxins are regulated by FDA due 
to their carcinogenic and hepatotoxic effects, and their presence as residues in chicken 
meat and egg. Therefore, it is critical to develop scientifically validated strategies for 
controlling aflatoxin in poultry feed and attenuate aflatoxicosis in chickens. 
        Based on published literature and preliminary research, this Ph.D. dissertation 
hypothesizes that CR and TC reduce A. flavus and A. parasiticus growth and aflatoxin 
production. Moreover, in-feed supplementation of CR and TC reduces aflatoxicosis in 
chickens. The specific objectives were: 
1. To study the effect of CR and TC on A. flavus and A. parasiticus growth, 
AF production, and expression of toxin synthesis genes in a broth system 
and in chicken feed during long-term storage. 
2. To determine the efficacy of CR and TC in reducing aflatoxin-induced 
toxicity on chicken embryos.  
3. To study the efficacy of in-feed supplementation of CR and TC in 
reducing aflatoxicosis in chickens. 
4. To investigate the effect of in-feed supplementation of CR and TC on the 
 35 
hepatic transcriptome of chicken exposed to aflatoxins.  
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ABSTRACT 
Aflatoxins (AF) are toxic metabolites primarily produced by molds, Aspergillus flavus 
and Aspergillus parasiticus. Contamination of poultry feed with AF is a major 
concern to the poultry industry due to severe economic losses stemming from poor 
performance, reduced egg production and diminished egg hatchability. This study 
investigated the inhibitory effect of two generally regarded as safe (GRAS), natural 
plant compounds, namely carvacrol (CR) and trans-cinnamaldehyde (TC), on A. 
flavus and A. parasiticus growth and AF production in potato dextrose broth (PDB) 
and in poultry feed. In broth culture, PDB supplemented with CR (0%, 0.02%, 0.04% 
and 0.08%) or TC (0%, 0.005%, 0.01% and 0.02%) was inoculated with A. flavus or 
A. parasiticus (6 log CFU/mL), and mold counts and AF production were determined 
on days 0, 1, 3, and 5. Similarly, 200 g portions of poultry feed supplemented with CR 
or TC (0%, 0.4%, 0.8%, and 1.0%) were inoculated with each mold, and their counts 
and AF concentrations in the feed were determined at 0, 1, 2, 3, 4, 8, and 12 weeks of 
storage. Moreover, the effect of CR and TC on the expression of AF synthesis genes 
in A. flavus and A. parasiticus (aflC, nor1, norA, and ver1) was determined using real-
time quantitative PCR (RT-qPCR). All experiments had duplicate samples and were 
 56 
replicated three times. Results indicated that CR and TC reduced A. flavus and A. 
parasiticus growth and AF production in broth culture and chicken feed (P < 0.05). 
All tested concentrations of CR and TC decreased AF production in broth culture and 
chicken feed by at least 60% when compared to controls (P < 0.05). In addition, CR 
and TC down-regulated the expression of major genes associated with AF synthesis in 
the molds (P < 0.05). Results suggest the potential use of CR and TC as feed additives 
to control AF contamination in poultry feed. 
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1. Introduction 
        Aflatoxins (AF) are a group of toxic metabolites of Aspergillus flavus and 
Aspergillus parasiticus. AF contaminate a variety of feed ingredients, including 
peanuts, corn and cottonseed (Oguz et al., 2000; Sur and Celik, 2003). Although at 
least 18 types of AF have been identified, only four types, namely AFB1, B2, G1, and 
G2, are commonly found in the feed (Leeson et al., 1995). Aflatoxin B1, listed as 
group I human carcinogen by the International Agency for Research on Cancer, is 
considered the most toxic (Yunus et al., 2011).  
        Contamination of poultry feed with AF is a major concern to the poultry industry 
since aflatoxicosis in chickens results in significant economic losses due to poor feed 
utilization, decreased body weight gain, reduced egg production and increased 
mortality (Qureshi et al., 1998; Tessari et al., 2006; Oguz, 2011). The negative effects 
of AF in poultry have been widely investigated (Giambrone et al., 1978; Celik et al., 
1996; Sur and Celik, 2003). AF ingested by chickens can accumulate in most of the 
soft tissues and fat depots resulting in hemorrhagic and fatty liver syndrome (Leeson 
et al., 1995; Bintvihok et al, 2002). In addition, AF residues found in poultry meat and 
eggs (Jacobson and Wiseman, 1974; Sudhakar, 1992; Qureshi et al, 1998) pose a 
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significant health hazard to humans due to their carcinogenic, teratogenic, and 
mutagenic properties (Ross et al., 1992; Bintvihok et al., 2002). Thus it is critical to 
control aflatoxins in poultry feed to protect public health, bird health, and ensure the 
economic viability of the poultry industry. Moreover, in light of the risks associated 
with aflatoxicosis in chicken, the U.S. Food and Drug Administration (USFDA) has 
established guidelines for the maximum total AF level permitted in poultry feed, 
which is 20 ppb in corn and peanut products for chicks, and 100 ppb in feed for adult 
chickens (FDA, 2009). 
        The economic loss due to mycotoxin contamination of crops and the cost of 
research and monitoring activities to control mycotoxins are estimated to range 
between $500 million and $1.5 billion a year (Abarca et al., 1994; Robens and 
Cardwell, 2003). However, cost-effective and practical methods to prevent AF 
contamination in poultry feed are currently limited. At present, the inclusion of AF-
binding adsorbent in feed is employed to protect birds from the harmful effects of AF. 
However, several adsorbents have been shown to impair nutrient utilization (Chung et 
al., 1990; Kubena et al., 1993; Scheideler et al., 1993) and mineral absorption in 
chickens (Chestnut et al., 1992; Edrington et al., 1997). It was concluded that none of 
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the current strategies to control AF are sufficient to completely fulfill the necessary 
safety and cost requirements (Teniola et al., 2005). This highlights the need for an 
effective strategy to control AF contamination in poultry feed.    
        Plant-derived essential oils are a group of natural, environmentally friendly 
antimicrobials that have traditionally been used as food preservatives and flavor 
enhancers. In the past decade, the use of plant-derived compounds has gained 
significant attention due to increasing concern over the safety of synthetic chemicals 
and emergence of antibiotic-resistant strains of microorganisms (Salamci et al., 2007). 
The antifungal and antitoxigenic properties of several plant oils have been identified 
(Burt et al, 2004). Carvacrol (CR) is a major ingredient in oregano oil (Origanum 
glandulosum), whereas trans-cinnamaldehyde (TC) is a principal component in 
cinnamon bark (Cinnamomum zeylandicum). Both these compounds are classified as 
generally recognized as safe (GRAS) for addition in food products by the FDA 
(Adams et al., 2004; Higueras et al., 2013). This study investigated the efficacy of CR 
and TC in reducing A. flavus and A. parasiticus growth and AF production in potato 
dextrose broth (PDB), and poultry feed during long–term storage. In addition, the 
effect of aforementioned plant-derived antimicrobials on A. flavus and A. parasiticus 
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toxin production genes was studied using real-time quantitative PCR (RT-PCR).  
2. Materials and Methods 
2.1 A. flavus and A. parasiticus inoculum preparation 
        Aspergillus flavus NRRL 3357 (A. flavus-3357) and A. parasiticus NRRL 4123 
(A. parasiticus-4123) obtained from USDA-ARS (NRRL) culture collection, Peoria, 
IL were used in this study. These mold isolates were tested for purity, and identified 
by growth on Aspergillus differentiation agar (ADA; catalogue no. 17121, Sigma-
Aldrich, St. Louis, MO). Aspergillus flavus and A. parasiticus were subcultured on 
potato dextrose agar (PDA; catalogue no. P6685, Sigma-Aldrich, St. Louis, MO) and 
incubated at 25oC for 5 days. Each inoculum was harvested by adding sterile water to 
the PDA slants to get the final mold concentration of 6 log CFU/mL (Farag et al., 
1989).  
2.2 Effect of CR and TC on mold growth and AF production in broth 
        The effect of CR and TC on growth and AF production by A. flavus and A. 
parasiticus was studied in potato dextrose broth (PDB), as described by Farag et al. 
(1989). Briefly, 10 mL of PDB was inoculated with A. flavus or A. parasiticus (6 log 
CFU/mL), followed by the addition of CR (catalogue no. W224502, Sigma-Aldrich, 
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St. Louis, MO) or TC (catalogue no. W228605, Sigma-Aldrich, St. Louis, MO). The 
final CR and TC concentrations in PDB were 0.02%, 0.04%, and 0.08%, and 0.005%, 
0.01%, and 0.02%, respectively. These concentrations were selected from preliminary 
experiments that screened the antifungal and antitoxin effect of a wide range of these 
compounds against several strains of A. flavus and A. parasiticus. Potato dextrose 
broth devoid of CR or TC served as the control. The inoculated broth supplemented 
with or without CR or TC was incubated at 25°C for 5 days. On days 0, 1, 3, and 5, 
the mold counts were enumerated on PDA plates following serial dilution in 
phosphate buffered saline (PBS, pH 7.0), and AF concentrations in the supernatant 
were determined using a commercial ELISA kit (AgraQuant total Aflatoxin, catalogue 
no. CAKAQ 1100, Romer Labs, Union, MO) (Salem and Ahmad, 2010).  
2.3 Effect of CR and TC on mold growth and AF production in feed 
        Layer-grower crumble feed free of any toxin binder was procured from 
University of Connecticut poultry farm. Prior to use, representative samples from the 
experimental feed were analyzed for A. flavus, A. parasiticus and AF concentration to 
ensure that there was no detectable AF contamination. The feed was inoculated with 
each mold separately using the method described by Kusumaningtyas et al. (2006), 
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wherein A. flavus-3357 or A. parasiticus-4123 was added to 200 g portions of feed to 
obtain ~5 log CFU/g, and mixed well. After inoculation, the feed was added with CR 
or TC at 0%, 0.4%, 0.8% or 1.0% followed by incubation at 25oC for 3 months. A 
twenty-gram portion of the feed was sampled on weeks 0, 1, 2, 3, 4, 8 and 12, of 
which 10 g for mold enumeration and 10 g for AF detection were used.  
2.4 Determination of mold counts and aflatoxins in feed 
        To enumerate A. flavus and A. parasiticus in the control and treated feed, 10 g 
portions of feed samples were added to 40 mL of PBS in sterile whirl-pak bags 
(catalogue no. Z527017, Sigma-Aldrich, St. Louis, MO), and pummeled in a 
stomacher (Stomacher 400 Circulator, Seward, Davie, FL) for 1 min. The feed 
homogenate was serially diluted (1:10) in PBS, and 0.1 mL aliquots from appropriate 
dilutions were surface plated on duplicate PDA plates, and incubated as before.  
        The concentration of AF in the feed was quantitated using the aforementioned 
commercial ELISA kit (AgraQuant total Aflatoxin, catalogue no. CAKAQ 1100, 
Romer Labs, Union, MO). To prepare AF extracts, 10 g portions of feed were mixed 
with 40 mL of 70% methanol (70/30 methanol/water) (v/v) for sample extraction. One 
hundred μL of the sample extract was mixed with 200 μL of conjugate solution 
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provided in the kit. Following mixing, 100 μL of the solution was transferred to 
antibody-coated well and incubated for 15 min. After incubation, the content of each 
well was discarded, and the wells were washed five times with distilled deionized 
water. Any excess water was discarded and the wells were dried. One hundred 
microliters of the substrate solution were then added to each well, incubated for 5 min, 
and the reaction was stopped by adding 100 μL of stop solution. The optical density 
of the sample at 450 nm from each well was read in a spectrophotometer (Gen5 
spectrophotometer, Biotek, Winooski, VT). The total AF concentration was calculated 
by extrapolating the optical density from a calibration standard curve prepared with a 
wide range of AF concentrations (Zheng et al., 2005). The results were expressed in 
parts per billion (ppb).    
2.5 RNA isolation and RT-qPCR 
        The effect of CR and TC on the expression of A. flavus and A. parasiticus AF 
synthesis genes (aflC, nor1, norA, and ver1) was determined using RT-qPCR (Cuero 
et al., 2003). A. flavus or A. parasiticus was grown with or without the SIC (sub-
inhibitory concentration, the highest concentration that did not decrease mold growth) 
of CR (0.02%) and TC (0.005%) in 10 mL of PDB at 25oC for 5 days. Total RNA was 
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extracted from each sample using RNeasy Plant Mini RNA Kit (catalogue no. 74903, 
Qiagen, Valencia, CA). The RNA was quantified by measuring the absorbance at 260 
and 280 nm using a Nanodrop (Bio-Rad, Hercules, CA). Complementary DNA 
(cDNA) was synthesized using the Superscript II Reverse transcriptase kit (catalogue 
no. 18064-014, Life technology, Grand Island, NY), and RT-qPCR was performed 
with specific primers (Table 1) for aflC, nor1, norA, ver1, and β-tublin (endogenous 
control). Relative gene expression was determined by comparative critical threshold 
(Ct) method using a 7500 Fast Real-Time PCR system (Applied Biosystems). Data 
were normalized to the β-tublin and the level of candidate gene expression between 
treated and control samples was determined. 
2.6 Statistical analysis 
        Data from broth, poultry feed, and gene expression studies were analyzed 
separately. All studies were repeated three times with duplicate samples for each 
treatment and control. A repeated measures design with a factorial treatment structure 
was used in broth (2 x 4 x 4) and feed study (2 x 4 x 7). In broth study, the factors 
were 2 plant compounds (CR and TC), 4 treatment concentrations (CR at 0.01%, 
0.04%, and 0.08%; TC at 0.005%, 0.01%, and 0.02%) and 4 time points (day 0, 1, 3, 
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and 5 days). In the feed study, the factors were 2 plant compounds (CR and TC), 4 
treatment concentrations (CR or TC 0%, 0.4%, 0.8% and 1.0%) and 7 time points 
(week 0, 1, 2, 3, 4, 8 and 12 weeks). The data were analyzed using the PROC MIXED 
procedure of Statistical Analysis Software (SAS, version 9.3, SAS institute, Inc., Cary, 
NC, USA). The differences among the means were detected at P < 0.05 using Fisher’s 
least significance test (LSD). In the gene expression study, the differences between 
independent treatments were analyzed using two tailed t-test, and considered 
significant when P < 0.05.   
3. Results 
3.1 Effect of CR and TC on mold growth and AF production in broth  
        Figure 1 shows the effect of CR (0%, 0.02%, 0.04% and 0.08%) and TC (0%, 
0.005%, 0.01% and 0.02%) on A. flavus and A. parasiticus growth and AF production 
in PDB.  On day 0, approximately 4 to 4.5 log CFU/mL of mold counts were 
recovered from treated and control samples (Fig 1A and 1B). Although the mold 
counts between control and the lower concentrations of CR (0.02% and 0.04%) were 
not different throughout the incubation period (P > 0.05), CR at 0.08% completely 
inhibited the growth of both molds from day 1 through day 5. In contrast to this, all 
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tested CR concentrations reduced AF production by both mold species by more than 
95% when compared to control samples (Fig. 1C and 1D). Trans-cinnamaldehyde 
exerted a similar inhibitory effect on A. flavus and A. parasiticus growth and AF 
production (Fig 2). Although A. flavus and A. parasiticus growth was markedly 
inhibited by only the highest concentration of TC (0.2%) (Fig. 2 A and 2 B), AF 
synthesis by both molds was decreased by more than 90% at all tested TC 
concentrations (Fig. 2C and 2D). 
3.2 Effect of CR and TC on mold growth and AF production in feed   
        Carvacrol and TC exhibited a similar inhibitory effect on A. flavus and A. 
parasiticus growth and AF production in poultry feed. For example, the growth of 
both molds was significantly decreased by 0.8 and 1.0% CR from weeks 4 through 12, 
with 4.0 log and 3 log CFU/mL reductions in A. flavus and A. parasiticus populations, 
respectively at the end of the storage period (Fig. 3A and 3B). However, irrespective 
of the concentration, CR (0.4%, 0.8%, and 1.0%) decreased AF production by both 
molds by more than 60% at 12 weeks compared to control (P < 0.05) (Figure 3C and 
3D). Figure 4 shows the inhibitory effect of TC on A. flavus and A. parasiticus growth 
and AF production in feed, where it can be seen that TC (0.8% and 1.0%) reduced the 
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counts of both molds throughout the storage period (P < 0.05) (Fig. 4 A and 4B). 
Similar to CR, all concentrations of TC inhibited AF production by approximately 
60% by the end of storage period (P < 0.05) (Fig. 4 C and 4D).    
3.3 Effect of CR and TC on the expression of AF production genes  
        The effect of CR and TC on the expression of AF synthesis genes in A. flavus 
and A. parasiticus is presented in Fig. 5. Real-time quantitative PCR results revealed 
that the SIC of CR (0.02%) and TC (0.005%) down-regulated (P < 0.05) the 
expression of the majority of genes critical for AF synthesis in A. flavus and A. 
parasiticus (aflC, nor1, and norA) (P < 0.05). Compared to untreated controls, CR 
down-regulated the expression of nor1 and norA in A. flavus and A. parasiticus by > 
10 fold (Fig. 5 A and 5B), whereas TC reduced the expression of these genes by more 
than 4 fold (P < 0.05) (Fig. 5C and 5D).  
4.. Discussion 
        Aflatoxicosis in chickens is a serious problem affecting bird health, performance, 
and egg hatchability. In addition, the negative effects on public health due to the 
consumption of AF-contaminated poultry products constitute a significant hazard. 
Therefore, the development of practical and effective methods to control AF 
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contamination in feed is critical for the sustainability of the poultry industry. In this 
regard, a viable approach would be to prevent or minimize AF production by molds in 
poultry feed (Miedaner and Reinbrecht, 1999).    
        This study investigated the efficacy of CR and TC, two naturally occurring and 
GRAS-status plant compounds in inhibiting A. flavus and A. parasiticus growth and 
AF production. Although both plant compounds were effective in reducing AF 
production by A. flavus and A. parasiticus, no consequential association between the 
mold growth and AF production was observed. For example, although all tested CR 
concentrations inhibited AF production in PDB by greater 95%, only 0.08% of the 
compound was effective in significantly inhibiting mold growth (Fig. 1). Likewise, 
AF production was decreased by all tested concentrations of TC although mold 
growth was significantly inhibited only by 0.01 and 0.02% of the compound (Fig. 2). 
Similar results were also observed when the compounds were tested in poultry feed 
(Fig. 3 and Fig. 4). These findings concur with the study by Kusumaningtyas et al. 
(2006), who reported no correlation between the growth of A. flavus and AF 
production. Similarly, Bluma and Etchaverry (2006) reported that when A. flavus was 
grown in maize in the presence of Bacillus strains, the reduction in mold counts was 
 69 
less than 30%, but levels of detectable AFB1 were significantly reduced.  
        Since the results indicated that CR and TC decreased AF levels in the broth and 
feed substantially even with no or minimal inhibition on mold growth, we 
hypothesized that the reduction in AF synthesis may be due to any potential inhibitory 
effect of CR and TC on the genes involved in AF production in A. flavus and A. 
parasiticus. To test this, we analyzed the expression of critical AF synthesis genes in 
A. flavus and A. parasiticus treated with and without the SIC of CR or TC. Since the 
SICs of antimicrobials, including antibiotics can modulate microbial physico-
chemical functions, including that of genes, they are used for studying the effect of 
antimicrobials on gene expression and virulence in microorganisms (Goh et al. 2002; 
Fonesca et al., 2004; Tsui et al. 2004). The RT-qPCR data on gene expression revealed 
that both CR and TC significantly down-regulated the transcription of aflC, nor1, and 
norA, which are involved with AF synthesis in A. flavus and A. parasiticus (Fig. 5).  
In the AF biosynthesis pathway, aflC is involved in the conversion of acetate to 
norsolorinic acid (NOR), which is the first stable AF synthesis intermediate, whereas 
nor1 and norA are involved in the conversion of NOR to averatin (AVN), which 
subsequently undergoes several reactions in the pathway for AF synthesis (Yu et al., 
 70 
2004; Ehrlish et al., 2005). 
        Previous studies from our laboratory showed that plant compounds such as TC 
could be used as feed ingredients to reduce the colonization of Salmonella Enteritidis 
in chickens, without deleteriously affecting feed intake and body weight of birds 
(Kollanoor-Johny et al., 2012). Similarly, Arsi and coworkers (2011) observed that in-
feed supplementation of CR reduced Campylobacter jejuni carriage in broiler 
chickens. These findings suggest that CR and TC, especially due to their lipophilic 
nature, can be easily mixed with other feed ingredients in a poultry ration. The cost of 
TC is ~ $2/lb, whereas CR is reported to cost ~ $22/lb (Darre et al., 2014). However, 
the cost of these chemicals in bulk quantities is expected to be lower. Therefore, CR 
and TC could practically be used as ingredients in poultry feed to control aflatoxicosis, 
especially in light of the observed anti-toxigenic effect at concentrations as low as 
0.4% in the feed (Fig. 3 and Fig. 4). 
        In conclusion, this study demonstrated that CR and TC significantly inhibited A. 
flavus and A. parasiticus growth and AF production in broth and poultry feed (P < 
0.05). In addition, CR and TC down-regulated critical AF synthesis genes (aflC, nor1, 
norA, and ver1) in A. flavus and A. parasiticus. Our future studies will validate the 
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efficacy of the aforementioned plant compounds as feed additives in reducing 
aflatoxicosis in chickens.  
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Table 1. List of primers used for real-time quantitative PCR (RT-qPCR). 
 
Gene 
Accession 
number 
Gene Function Sequence (5’-3’) 
aflCF1 
aflCR2 
JF418554.1 
Polyketide 
synthase 
5’ TGCATGGCGATGTGGTAGTT 3’ 
5’ GTAAGGCCGCGAGAGAAAG 3’ 
nor1F 
nor1R 
EF565463.1 Reductase 
5’ GGCAACCCGCCTGATG-3’ 
5’ GGCGCCGATCAAGACAAA 3’ 
norAF 
norAR 
AB618249.1 
NOR3 Reductase/ 
dehydrogenase 
5’-TCTAGCGCCGGTGTTCGT 3’ 
5’-TTACCCCTTTCCAGCCATTG 3’ 
ver1F 
ver1R 
AY987856.2 
Dehygrogenase/ 
ketoreductase 
5’ GCGGAGAAGGTAGTTCAACAGATC 3’ 
5’ GACATCGGCCTGGATTGC 3’ 
ß-tublinF 
ß-tublinR 
JF740161.1 
Endogenous 
control 
5’ CGTGTCGGCGACCAGTTC 3’ 
5’ CCTCACCAGTGTACCAATGCA 3’ 
1F: Forward primer; 2R: Reverse primer; 3NOR: norsolorinic acid. 
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Figure 1. Effect of carvacrol (CR) at 0.02%, 0.04%, and 0.08% on Aspergillus flavus 
NRRL 3357 and Aspergillus parasiticus NRRL 4123 growth and aflatoxin production 
in broth. Data are the mean ± SEM obtained from 3 separate experiments with 
duplicate samples on each sampling point (0, 1, 3, and 5 day). Error bar indicates 
SEM (n=6). Fig. 1A and 1B show the growth of A. flavus and A. parasiticus, whereas 
Fig. 1C and 1D show AF production by the molds. 
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Figure 2. Effect of trans-cinnamaldehyde (TC) at 0.005, 0.01, and 0.02% on 
Aspergillus flavus NRRL 3357 and Aspergillus parasiticus NRRL 4123 growth and 
aflatoxin production in broth. Data are the mean ± SEM obtained from 3 separate 
experiments with duplicate samples on each sampling point (0, 1, 3, and 5 day). Error 
bar indicates SEM (n=6). Fig. 2A and 2B show the growth of A. flavus and A. 
parasiticus, respectively, whereas Fig. 2C and 2D show AF production by the molds. 
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Figure 3. Effect of Carvacrol (CR) at 0.4, 0.8, and 1.0% on Aspergillus flavus NRRL 
3357 and Aspergillus parasiticus NRRL 4123 growth and aflatoxin production in 
poultry feed. Data are the mean ± SEM obtained from 3 separate experiments with 
duplicate samples on each sampling point (0, 1, 2, 3, 4, 8, 12 week). Error bar 
indicates SEM (n=6). Fig. 3A and 3B show the growth of A. flavus and A. parasiticus, 
respectively, whereas Fig. 3C and 3D show AF production by the molds.  
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Fig 4. Effect of trans-cinnamaldehyde (TC) at 0.4, 0.8, and 1.0% on Aspergillus 
flavus NRRL 3357 and Aspergillus parasiticus NRRL 4123 growth and aflatoxin 
production in poultry feed. Data are the mean ± SEM obtained from 3 separate 
experiments with duplicate samples on each sampling time point (0, 1, 2, 3, 4, 8, 12 
week). Error bar indicates SEM (n=6). Fig. 4A and 4B show the growth of A. flavus 
and A. parasiticus, respectively, whereas Fig. 4C and 4D show AF production by the 
molds.  
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Figure 5. Effect of SIC of carvacrol (CR) (0.02%) and trans-cinnamaldehyde (TC) 
(0.005%) on the expression of aflatoxin synthesis genes in Aspergillus flavus NRRL 
3357 and Aspergillus parasiticus NRRL 4123. Data are the mean ± SEM obtained 
from 6 replicate samples. Error bar indicate SEM (n=6). Fig. 5A and 5B show the 
effect of CR on AF synthesis gene expression in A. flavus and A. parasiticus. Fig. 5C 
and 5D show the effect of TC on AF synthesis gene expression in A. flavus and A. 
parasiticus, respectively.  
 
 
 
 
 
 83 
 
 
 
 
 
 
 
Chapter IV 
Phytochemicals reduce aflatoxin-induced toxicity in chicken embryos 
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ABSTRACT 
Aflatoxins (AF) are toxic metabolites produced by molds, Aspergillus flavus and 
Aspergillus parasiticus, which frequently contaminate poultry feed ingredients. 
Ingestion of AF-contaminated feed by chickens leads to deleterious effects, including 
decreased bird performance and reduced egg production. Moreover, AF residues in 
fertilized eggs result in huge economic losses by decreasing embryo viability and 
hatchability. This study investigated the efficacy of two generally recognized as safe 
phytochemicals, namely carvacrol (CR) and trans-cinnamaldehyde (TC), in protecting 
chicken embryos from AF-induced toxicity. Day-old embryonated eggs were injected 
with 50 ng or 75 ng AF with or without 0.1% CR or TC, followed by incubation in a 
hatching incubator for 18 days. Relative embryo weight, yolk sac weight, tibia weight, 
tibia length, and mortality were recorded on day 18 of incubation. The effect of 
phytochemicals and methanol (diluent) on embryo viability was also determined. 
Each experiment had ten treatments with 15 eggs/treatment (n=150 eggs/experiment) 
and each experiment was replicated three times. Both phytochemicals significantly 
decreased AF-induced toxicity in chicken embryos. At 75 ng of AF/egg, CR and TC 
increased the survival of chicken embryo by ~ 55%. Moreover, CR and TC increased 
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relative embryo weight by ~ 3.3% and 17% when compared to eggs injected with 50 
ng or 75 ng AF, respectively. The growth of embryos (tibia length and weight) was 
improved in phytochemical-treated embryos compared to those injected with AF 
alone (p<0.05). Phytochemical and methanol treatments did not adversely affect 
embryo survival, and other measured parameters (p>0.05). Results from this study 
demonstrate that CR and TC could reduce AF-induced toxicity in chicken embryos; 
however, additional studies are warranted to delineate the mechanistic basis behind 
this effect.  
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1. Introduction 
        Aflatoxins (AF) are a group of toxic metabolites of Aspergillus flavus and 
Aspergillus parasiticus, which can frequently contaminate a variety of feed 
ingredients, including peanuts, corn and cottonseed (Oguz et al., 2000; Sur and Celik, 
2003). Among the four types of AF identified in feed, Aflatoxin B1 (AFB1) is one of 
the most potent hepatocarcinogens, and has been listed as a group I human carcinogen 
by the International Agency for Research on Cancer (Yunus et al., 2011).  
        Contamination of poultry feed with AF is a major concern to the poultry industry, 
since aflatoxicosis in chickens results in significant economic losses due to poor feed 
utilization, decreased body weight gain, reduced egg production and increased 
mortality (Qureshi et al., 1998; Tessari et al., 2006; Oguz, 2011). Once ingested by 
chickens, AF can accumulate in most of the soft tissues and fat depots of the chicken, 
and cause hemorrhagic and enlarged liver (Leeson et al., 1995; Bintvihok et al, 2002). 
Furthermore, during egg formation, AF residues could be transferred from the laying 
hen to the fertilized eggs, thereby resulting in decreased embryo viability and 
hatchability (Qureshi et al., 1998), and causing several organ malformations (Cilievici 
et al., 1979). In addition, the carry-over AF from layer’s feed to the embryonated eggs 
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has also been attributed to retarding the development of chicken embryos as well as 
inhibit the growth of bone tissue, especially tibia in chickens (Huff et al., 1980; Celik 
et al., 2000).  
        Despite the ill effects of aflatoxicosis in chickens, cost-effective and practical 
methods to prevent AF contamination in poultry feed are currently limited. At present, 
the inclusion of AF-binding adsorbents in feed is employed to protect birds from the 
harmful effects of AF. However, several adsorbents have been shown to impair 
nutrient utilization (Chung et al., 1990; Kubena et al., 1993; Scheideler, 1993) and 
mineral absorption in chickens (Chestnut et al., 1992; Edrington et al., 1997). Thus, 
there is a need for an effective strategy to control aflatoxicosis in chickens.    
  In the past decade, the use of phytochemicals has gained significant attention 
due to increasing concern over the safety of synthetic chemicals and emergence of 
antibiotic-resistant strains of microorganisms (Salamci et al., 2007). The antifungal 
and antitoxigenic properties of several plant oils have been identified (Upadhyaya et 
al., 2014). Carvacrol (CR) is a major ingredient in oregano oil (Origanum 
glandulosum), whereas trans-cinnamaldehyde (TC) is a principal component in 
cinnamon bark (Cinnamomum zeylandicum). Both of these compounds are classified 
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as generally recognized as safe (GRAS) for addition in food products by the US Food 
and Drug Administration (USFDA) (Adams et al., 2004; Higueras et al., 2013).   In 
previous studies, TC has been supplemented to chicken feed to reduce the 
colonization of Salmonella Enteritidis in chickens without deleteriously affecting feed 
intake and body weight of the birds (Kollanoor-Johny et al., 2012). Similarly, CR has 
also been used as a feed additive to decrease Campylobacter jejuni carriage in 
chickens (Arsi et al., 2014). These findings suggest that CR and TC, especially due to 
their lipophilic nature, could be mixed with other feed ingredients in a poultry ration. 
In this study, we investigated the efficacy of CR and TC in protecting chicken 
embryos from AF-induced toxicity. 
2. Materials and Methods 
2.1 Experimental designs 
        Pure AFB1 (aflatoxinB1, 20 μg/ml in 100% methanol, catalogue no. CRM44647, 
Sigma-Aldrich, St. Louis, MO) was diluted with sterile double-distilled water to 
obtain final concentrations of 50 ng/20uL or 75 ng/20uL of AFB1 in 20% methanol. 
The AFB1 concentration of the solutions was measured using a commercial ELISA 
kit (AgraQuant total Aflatoxin, catalogue no. CAKAQ 1100, Romer Labs, Union, 
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MO). To prepare the phytochemical treatments, CR or TC (99% purity, catalogue no. 
W224502 and W228605, Sigma-Aldrich, St. Louis, MO) was added to the 
aforementioned solution containing 50 ng or 75 ng of AFB1 to obtain a final 
concentration at 0.1% of CR or TC in the 20ul injection volume. 
        Freshly laid fertile eggs from single-comb White Leghorn (Lohmann LSL-Lite, 
Lohmann Tierzucht GmbH, Am Seedeich 9-11,27472 Cuxhaven, Germany) layer 
chickens were procured from the University of Connecticut poultry farm. The various 
treatments used in this study included (1) Negative control (eggs with no injection), (2) 
0.1% CR control (eggs injected with 0.1% CR), (3) 0.1% TC control (eggs injected 
with 0.1% TC), (4) Methanol control (eggs injected with 20% methanol), (5) AF 50 
ng (eggs injected with 50 ng AFB1), (6) AF 75 ng (eggs injected with 75 ng AFB1), 
(7) AF 50 ng + 0.1% CR (eggs injected with 50 ng AFB1 and 0.1% CR), (8) AF 50 ng 
+ 0.1% TC (eggs injected with 50 ng AFB1 and 0.1% TC), (9) AF 75 ng + 0.1% CR 
(eggs injected with 75 ng AFB1 and 0.1% CR), (10) AF 75 ng + 0.1% TC (eggs 
injected with 75 ng AFB1 and 0.1% TC). Following the treatments, eggs were 
incubated by placing in an incubator (catalogue no. 2362N hova-bator, GQF 
Manufacturing Company Inc., Savannah, GA) at 37.8oC and 65% relative humidity, 
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with eggs being turned through 270o every 2 h during incubation.  
        In total, one hundred and fifty fertile eggs were used for each study, and the 
study was repeated three times. The eggs were weighed and divided into 10 groups 
with 15 eggs per group. All eggs were candled to determine the viability of the fertile 
eggs, and the treatments were applied just prior to placing the eggs in the incubator 
(Celik et al., 2000; Oznurlu et al., 2012). To inject the eggs, 20 μl of each 
aforementioned treatment solution was injected into the air space on the blunt end of 
the egg using pipettes with sterile tips (Celik et al., 2000). After injection, the hole 
was immediately sealed with melted paraffin (Oznurlu et al., 2012). The injected eggs 
were incubated for 18 days.  
2.2 Effect of phytochemicals on the growth of embryo when exposed to AFB1  
        On day 18 of incubation, fifteen eggs containing developing embryos from each 
treatment group were individually weighed using a digital balance (sensitivity g±0.01, 
catalogue no. 01-919-370, Fisher Scientific Co., Fair Lawn, NJ). The eggs were 
opened, and the weights of the yolk sac and embryo were recorded for each egg 
individually. The developmental stage of each embryo was determined according to 
the Hamburger-Hamilton scale (Hamburger and Hamilton, 1951). The mean relative 
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embryo weight and relative yolk sac weight of each group were calculated using the 
equations as provided below:  
Relative embryo weight = [(embryo weight/egg weight x 100)]; Relative yolk sac 
weight = [(yolk sac weight/egg weight) x 100] 
2.3 Effect of phytochemicals on the development of tibia in chicken embryo when 
exposed to AFB1  
       Tibia from each embryo was removed, cleared of muscle and connective tissues, 
and weighed. Tibia weights were expressed as relative tibia weight [(tibia 
weight/embryo weight x 100)]. Tibia length was measured using a digital caliper 
(sensitivity: mm±0.01).  
2.4 Statistical analysis  
        Each experiment had ten treatments with 15 eggs/treatment (n=150 
eggs/experiment) and each experiment was replicated three times. A completely 
randomized design was used and egg was the experimental unit. The relative yolk sac 
weight, embryo weight, tibia weight, and tibia length were analyzed by PROC-
GENMODE procedure of the statistical analysis software (SAS, version 9.2; SAS 
Institute Inc., Cary, NC). Differences among the means were detected with a p value < 
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0.05, using Fisher’s least significance difference (LSD).  
3. Results 
3.1 Effect of phytochemicals on embryo mortality when exposed to AFB1  
        Table 1 shows the mortality rates of embryos from all the treatment groups used 
in this study. In control groups (negative, methanol, CR, and TC controls), mortalities 
ranging from 4 to 9% with no developmental abnormalities observed. Mortality rates 
in eggs injected with 50 ng AFB1 was 16%; however, a significantly greater mortality 
of 68% was noticed when the eggs were exposed to 75 ng AFB1. Although no 
significant difference was observed in the mortality rates between eggs treated with 
50 ng AFB1 (16%) and 50 ng AFB1 + CR/TC (14% and 13%), 0.1% CR and TC 
significantly reduced embryo mortality to 38% in the presence of 75 ng AFB1 
(p<0.05). 
3.2 Effect of phytochemicals on embryo weight and yolk sac weight when exposed 
to AFB1 
        The relative embryo weight and relative yolk sac weight of all treatments and 
controls on day 18th of incubation are depicted in Fig.  1a. and Fig.  1b. Results 
revealed that injection of eggs with 20% methanol, 0.1% CR, or 0.1% TC did not 
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significantly affect the relative embryo weight and relative yolk sac weight when 
compared with the negative control (p>0.05). Eggs injected with 50 ng AFB1 
demonstrated significantly lowered relative embryo weight as compared to the 
negative control (p<0.05). Although no significant difference in the relative embryo 
weights between AF 50 group and AF 50 + 0.1% CR groups (p>0.05) was observed, 
eggs treated with 0.1% TC in the presence of 50 ng AFB1 demonstrated greater 
relative embryo weights compared to those injected with 50 ng AFB1/egg alone (Fig 
1a, Fig. 3).  
        Relative yolk sac weight of eggs injected with 50 ng AFB1/egg was found to be 
significantly increased as compared to the negative control and methanol control 
(p<0.05). In addition, 0.1% TC significantly decreased the relative yolk sac weight of 
eggs treated with 50 ng AFB1. However, as the AFB1 concentration increased to 75 
ng/egg, no difference in relative yolk sac weights was observed between eggs injected 
with AFB1 and AFB1+phytochemical (p>0.05). 
3.3 Effect of phytochemicals on embryo tibia length and weight when exposed to 
AFB1 
        The effects of phytochemicals on tibia development in embryos exposed to 
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AFB1 are shown in Fig.  2a. and 2b. Results revealed that the average relative tibia 
weight of AFB1-injected embryos decreased in a dose-dependent manner in 
comparison to controls (p<0.05). However, CR and TC increased the relative tibia 
weight by 3.7% and 5%, respectively in embryos injected with 75 ng AFB1 as 
compared to embryos exposed to AFB1 75 ng alone. Moreover, injection of 0.1% CR 
and TC in the presence of 50 ng AFB1 significantly increased the embryo tibia length 
by 14% as compared to the AF50 group.  
4. Discussion 
        Aflatoxins can frequently contaminate chicken feed ingredients causing 
aflatoxicosis in birds resulting in decreased growth performance and increased 
susceptibility to infectious diseases. In addition, the transfer of AF from hens to eggs 
not only poses a threat to public health, but the residual AF can deleteriously affect 
embryo viability and hatchability, and potentially result in organ malfunctions 
(Cilievici et al., 1979; Qureshi et al., 1998; Sur et al., 2011). Thus, effective methods 
to protect fertilized eggs from aflatoxicosis is critical for the sustainability of the 
poultry industry. 
        Previous studies have reported that the development of chicken embryos was 
 95 
adversely affected in the presence of 10-100 ng of AFB1/egg (Celik et al., 2000; 
Oznurlu et al., 2012). Therefore, in the present study, we investigated the efficacy of 
CR and TC in protecting chicken embryos from AFB1 toxicity at concentrations, 
namely 50 ng AFB1/egg or 75 ng AFB1/egg. Our results revealed that the higher dose 
of AFB1 caused significant embryonic mortality (68%), whereas 50 ng AFB1/egg 
only resulted in 16% mortality (Table 1.) Additionally, the presence of 0.1% CR or 
TC significantly reduced the mortality rates to 14% or 13% and 38% when embryos 
were exposed to 50 ng or 75 ng AFB1/egg, respectively.  
        One of the major effects of aflatoxicosis on birds is decreased body weight, 
which directly affects the profitability of the poultry industry. Aflatoxin B1 is known 
to cause inhibition of RNA and DNA synthesis, thereby consequently reducing 
protein synthesis, which ultimately reduces growth (Hatch, 1988; Khlangwiset et al., 
2011). As expected, egg injection with 50 ng or 75 ng of AFB1 significantly 
decreased the relative embryo weight compared to controls (Fig. 1a). However, both 
phytochemicals improved the embryo weight despite exposure to AFB1, suggesting 
the potential protective effect of CR and TC to AFB1-injected embryos (Fig. 3). 
        Additionally, egg yolk is the main energy source for the developing embryo, 
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which supplies more than 90% of the total energy requirements of the embryo by 
oxidation of yolk lipids (Speake et al., 1998; Réhault-Godbert et al., 2014). The yolk 
sac is an external extra-embryonic tissue that surrounds the yolk, and absorbs, digests, 
and transports nutrients during incubation of the chicken embryo (Yadgary et al., 
2014). Moreover, yolk sac and yolk content are essential for supporting the 
development of the embryo during the entire phase of embryogenesis (Speake et al., 
1998; Yalcin et al., 2008). In the present study, we found a significant increase of 
relative yolk sac weight in eggs injected with 50 ng AFB1 compared to controls, 
which indicates reduced development of the embryos in the toxin-treated eggs. This 
concurs with our embryo weight data (Fig. 1a), which revealed that the relative 
embryo weights were significantly reduced in AFB1-injected eggs.  
        Aflatoxin B1 has also been reported to inhibit the development and growth of 
bone tissue in chickens, resulting in the retardation of the skeleton system 
development, especially the tibia (Huff et al., 1980). In the present study, 50 ng of 
AFB1/egg reduced tibia length, whereas 75 ng of AFB1/egg reduced relative tibia 
weight and tibia length compared to the negative control (p<0.05). Supplementation 
of 0.1% CR or TC in the presence of 50 ng AFB1/egg significantly improved the 
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relative tibia length as compared to embryos injected with AFB1 alone (p<0.05). 
However, the protective effects of CR and TC on the embryos did not persist when the 
AFB1 level was increased to 75 ng/egg, where no significant improvement in tibia 
length was observed in the presence of 0.1% CR or 0.1% TC as compared to controls 
(Fig. 2b.).  
         The toxic effects of AFB1 are well documented (Moudgil et al., 2013; Bahey et 
al., 2015), where several studies have confirmed that AFB1 is metabolized to a more 
active form, AFB1-2,3 epoxide, by cytochrome P450 family enzymes in the liver. 
This active compound avidly binds to N-guanine in DNA, and is shown to mediate 
cytotoxic, carcinogenic, and mutagenic effects (Eaton and Gallagher, 1994; Oznurlu 
et al., 2012). Although there is scanty information about the detoxification 
mechanisms of early embryonic cells, studies have shown that chicken embryos 
obtain the ability of detoxification shortly after the development of liver by day 5 to 
day 6 of incubation, (Hamilton and Bloom, 1986; Zhao and Duncan, 2005).  Although 
the mechanism(s) of the protective effects of phytochemicals to AF-induced toxicity 
to chicken embryos have not yet been documented, Abdel-Aziem et al. (2014), while 
evaluating the hepatoprotective effect of thyme leave extracts (contains CR) on AF-
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induced oxidative stress, genotoxicity, and alteration of p53 and bal gene expressions 
in rats, observed that animals treated with the extracts showed a significant decrease 
in oxidative damage markers, micronucleated cells, DNA fragmentation, and 
modulation of the expression of pro-apoptotic genes. Thus, the reduced AF toxicity 
observed in the chicken embryos could potentially be attributed to the protective 
effects of the phytochemicals in the liver. However, more in-depth molecular 
investigations need to be performed to elucidate the protective mechanisms of the 
phytochemicals.  
        In previous studies, TC has been supplemented to chicken feed to reduce the 
colonization of Salmonella Enteritidis in chickens without deleteriously affecting feed 
intake and body weight of birds (Kollanoor-Johny et al., 2012). Similarly, CR has also 
been used as a feed additive to decrease Campylobacter jejuni carriage in chickens 
(Arsi et al., 2014). These findings suggest that CR and TC, especially due to their 
lipophilic nature, could be mixed with other feed ingredients in a poultry ration.  
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Table 1. Effect of 0.1% carvacrol and 0.1% trans-cinnamaldehyde on embryo 
mortality when exposed to 50 ng or 75 ng AFB1/egg for 18 days.1,2  
Group Mortality 
Control 7% 
Methanol 5% 
CR 4% 
TC 7% 
AF50 16% 
AF50 CR 14% 
AF50 TC 13% 
AF75 68% 
AF75 CR 38% 
AF75 TC 38% 
1Control: eggs with no injection; Methanol: eggs injected with 20% methanol; CR: 
eggs injected with 0.1% CR only; TC: eggs injected with 0.1% TC only; AF50: eggs 
injected with 50 ng AFB1; AF 50 CR: eggs injected with 50 ng AFB1 and 0.1% CR; 
AF 50 TC: eggs injected with 50 ng AFB1 and 0.1% TC; AF 75: eggs injected with 75 
ng AFB1; AF 75 CR: eggs injected with 75 ng AFB1 and 0.1% CR; AF 75 TC: eggs 
injected with 75 ng AFB1 and 0.1% TC. 2Each treatment group had 45 eggs/treatment. 
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Figure 1. Effect of carvacrol and trans-cinnamaldehyde on the growth of chicken 
embryo when exposed to AFB1 at 50 ng and 75 ng /egg. Data are the mean ± SEM 
obtained from 3 separate experiments with 15 eggs per treatment group. Error bar 
indicates SEM (n=45/treatment). Fig. 1a shows the relative embryo weight and 1b 
shows the relative yolk sac weight. a-c Means treatments differed significantly from 
the negative control (p<0.05).  
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Figure 2. Effect of carvacrol and trans-cinnamaldehyde on the development of tibia 
in chicken embryo when exposed to AFB1 at 50 ng and 75 ng /egg. Data are the mean 
± SEM obtained from 3 separate experiments with 15 eggs per treatment group. Error 
bar indicates SEM (n=45/treatment). Fig. 1a shows the relative tibia weight and 1b 
shows the tibia length. a-d Means treatments differed significantly from the negative 
control (p<0.05). 
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Figure 3. Chicken embryos from different treatments. Treatments include Control: 
eggs with no injection; Methanol: eggs injected with 20% methanol; CR: eggs 
injected with 0.1% CR only; TC: eggs injected with 0.1% TC only; AF50: eggs 
injected with 50 ng AFB1; AF 50 CR: eggs injected with 50 ng AFB1 and 0.1% CR; 
AF 50 TC: eggs injected with 50 ng AFB1 and 0.1% TC; AF 75: eggs injected with 75 
ng AFB1; AF 75 CR: eggs injected with 75 ng AFB1 and 0.1% CR; AF 75 TC: eggs 
injected with 75 ng AFB1 and 0.1% TC. 
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Chapter V 
Efficacy of in-feed supplementation of phytochemicals in reducing aflatoxicosis 
in chickens 
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ABSTRACT 
Aflatoxins (AF) are a group of secondary metabolites produced by Aspergillus flavus 
and Aspergillus parasiticus, which frequently contaminate a variety of poultry feed 
ingredients. Contamination of poultry feed with AF is a major concern to the poultry 
industry since aflatoxicosis in chickens results in significant economic losses due to 
poor feed utilization, decreased body weight, and increased mortality. In this study, 
we investigated the efficacy of two generally recognized as safe phytochemicals, 
namely carvacrol (CR) and trans-cinnamaldehyde (TC), in controlling aflatoxicosis in 
chickens. Day-old broiler chicks were fed with AF contaminated feed (~2.5 µg/g) 
with or without in-feed supplementation of 0.75% CR or TC for 5 weeks. In weeks 2, 
3, 4, and 5, chicken performance traits, including body weight, feed intake, and feed 
conversion rate were measured. In addition, the relative weights of liver, spleen, and 
bursa of Fabricius were determined, and histologic analysis of liver was performed. 
Results revealed that CR and TC supplementation in AF-contaminated feed 
ameliorated AF-induced adverse effects in chickens. In addition, phytochemical 
supplementation significantly decreased relative liver weight and improved relative 
bursa of Fabricius weight in birds, as compared to AF-treated group (P < 0.05). 
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Histologic analysis revealed that CR and TC reduced AF-induced toxic effects in the 
liver of birds, where phytochemical-treated chickens had decreased hepatocellular 
degeneration, necrosis and inflammation in the liver as compared to chickens fed with 
AF alone. Results suggest that CR and TC could potentially be used as feed additives 
to control aflatoxicosis in broiler chickens.  
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1. Introduction  
       Aflatoxins (AF) are a group of fungal toxic metabolites of Aspergillus flavus and 
Aspergillus parasiticus. Among the 18 types of identified AF, AFB1, B2, G1, and G2 
are the natural contaminants of a variety of feed ingredients, including peanuts, corn 
and cottonseed (Oguz et al., 2000; Sur and Celik, 2003). In addition, AFB1 is 
considered to be one of the most potent hepatotoxins and well-known 
hepatocarcinogens (Wilson and Payne, 1994). Contamination of poultry feed with AF 
is a significant concern to the poultry industry since aflatoxicosis in chickens results 
in significant economic losses due to poor feed utilization, decreased body weight, 
reduced egg production, and increased mortality (Qureshi et al., 1998; Tessari et al., 
2006; Oguz, 2011). Since the first outbreak of AF contamination occurred in 1960, the 
negative effects of AF in poultry have been widely investigated (Giambrone et al., 
1978; Celik et al., 1996; Sur and Celik, 2003). Once ingested by chickens, AF can 
accumulate in most of the soft tissues and fat depots of birds resulting in hemorrhagic 
and enlarged liver (Leeson et al., 1995; Bintvihok et al, 2002). In addition, AF 
residues found in poultry meat and eggs (Jacobson and Wiseman, 1974; Sudhakar, 
1992; Qureshi et al, 1998) pose a significant health hazard to humans due to their 
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carcinogenic, teratogenic, and mutagenic properties (Ross et al., 1992; Bintvihok et 
al., 2002). Thus, it is critical to control aflatoxicosis in poultry to protect public health, 
bird health, and ensure the economic viability of the poultry industry.  
         The Food and Agriculture Organization reported that 25% of the world’s grains 
are contaminated by mycotoxins, and AF contamination is the most common among 
them. The economic losses due to AF contamination to the US poultry industry 
exceed $143 million annually (CAST, 1989). However, cost-effective and practical 
methods to prevent AF contamination in poultry feed are currently limited. At present, 
the inclusion of AF-binding adsorbents in feed is employed to protect birds from the 
harmful effects of AF. However, several adsorbents have been shown to impair 
nutrient utilization (Chung et al., 1990; Kubena et al., 1993; Scheideler et al., 1993) 
and mineral absorption in chickens (Chestnut et al., 1992; Ramos et al., 1996; 
Edrington et al., 1997). It was concluded that none of the current strategies to control 
AF are sufficient to completely fulfill the necessary safety and cost requirements 
(Teniola et al., 2005). This highlights the need for an effective strategy to control 
aflatoxicosis in chickens. 
       Historically, plants have served as a source for the development of novel drugs, 
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thereby contributing to human health and well-being (Cowan, 1999). A variety of 
phytochemicals have traditionally been used as food preservatives and flavor 
enhancers (Pitasawat et al., 2007). Among the various phytochemicals, carvacrol (CR), 
listed as generally recognized as safe (GRAS) by the FDA, is a major component in 
oregano oil obtained from Origanum vulgare (Lamiaceae). Carvacrol has been found 
effective against bacterial and fungal infections of the gastrointestinal and 
genitourinary tract (Blumenthal et al., 2000; Adams et al., 2004; Chun et al., 2005) as 
well as against a wide range of pathogens, including Staphylococcus aureus, 
Escherichia coli, and Streptococcus pneumoniae (Hersch-Martinez et al., 2005). 
Trans-cinnamaldehyde (TC) is another GRAS-status ingredient present in the bark 
extract of cinnamon (Cinnamomum zeylandicum). Various studies have demonstrated 
the antimicrobial properties of TC against both gram-negative and -positive bacteria 
(Burt, 2004; Upadhyaya et al., 2014). Previously, we observed that CR and TC were 
effective in killing A. flavus and A. parasiticus as well as reducing AF production in 
chicken feed for up to 3 months of storage (Yin et al., 2015). In the current study, we 
investigated the efficacy of in-feed supplementation of CR and TC in reducing 
aflatoxicosis in chickens. 
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2. Materials and Methods 
2.1 Method of AF production  
         To ensure AF production in adequate quantity for bird feeding experiments, a 
published protocol using rice as an initial substrate for AF production was used 
(Shotwell et al., 1966; Schroeder et al. 1973; Gowda et al., 2008). Briefly, 100 g of 
rice placed in a 1 liter Erlenmeyer flask was cleaned, washed, and immersed in 15 ml 
of sterile water for at least 2 hours. After 2 hours, rice was autoclaved and inoculated 
with 10 ml of A. parasiticus NRRL 2999 inoculum (~ 108 CFU/ml). Flasks were 
incubated at 27oC for 24 hours followed vigorous shaking in a shaking incubator at 
250 rpm at 25oC for 7 days. After incubation, the rice was dried and ground in an 
electric blender, and its AFB1 concentration was determined using a commercial 
ELISA kit (AgraQuant Aflatoxin B1, catalogue no. CAKAQ 8000, Romer Labs, 
Union, MO, USA). Based on the AFB1 level detected in the rice powder, appropriate 
amounts of the powder were added to chicken feed to reach a final concentration of 
2.5 µg/g in the feed. Additionally, experimental feed in the phytochemical-treated 
groups was supplemented with CR or TC (99% purity, catalogue no. W224502 and 
W228605, Sigma-Aldrich, St. Louis, MO, USA) to obtain 0.75% (vol/wt) in the feed. 
 115 
This concentration was selected based on a previous study from our laboratory, where 
in-feed supplementation of 0.75% TC produced no deleterious effects on chicken 
performance (Kollanoor-Johny et al., 2012). 
2.2 Experimental birds and housing 
        All experiments were approved by the Institutional Animal Care and Use 
Committee (IACUC) at the University of Connecticut. Day-old broiler chicks (Ross x 
Ross) were obtained from a commercial hatchery and randomly assigned to floor pens 
provided with ad libitum feed, water, age-appropriate ambient temperatures, and 
bedding at the Poultry Isolation Facility of the University of Connecticut. Mortality 
was recorded as it occurred, and birds were inspected daily for signs of health-related 
problems. 
2.3 Broiler chickens, diets, and management 
        A total of 240 chickens were randomly assigned to 6 different treatments with 20 
birds per pen and two pens per treatment. The 6 treatment groups included: (1) 
Control (feed with no AF and no CR/TC supplementation), (2) CR control (feed with 
no AF, but 0.75% supplemental CR), (3) TC control (feed with no AF, but 0.75% 
supplemental TC), (4) AF (feed containing ~2.5 µg/g AF), (5) AF+CR (feed 
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containing ~2.5 µg/g AF and 0.75% supplemental CR), and (6) AF+TC (feed 
containing ~2.5 µg/g AF and 0.75% supplemental TC). Control and treatment feed 
was provided for the entire experimental period of 35 days.  
2.4 Growth performance 
        Five birds per pen per treatment were euthanized using CO2 asphyxiation in 
weeks 2, 3, 4, and 5. Individual body weight (BW) was measured at each time point. 
Average feed intake and body weight gain was corrected for mortality when 
calculating feed conversion ratio (FCR) as kg feed consumed/ kg body weight gain 
for each treatment.  
2.5 Organ sample collection 
         At each time point (week 2, week 3, week 4, and week 5), entire organs of liver, 
spleen, and bursa of Fabricius were collected and weighed (Aravind et al., 2003). 
Relative organ weights were calculated as a percentage of BW. 
2.6 Histologic examination of liver  
        In weeks 3 and 5, a portion of liver from three different birds from each group 
was rapidly fixed in 10% neutral buffered formalin solution for at least 24 hours, and 
stored at room temperature until subjected to histologic analysis (Tedesco et al., 2004). 
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The liver samples were dehydrated through a graded series of ethanol, cleared in 
xylene, embedded in paraffin wax, and sectioned at 5 µm with microtome. The 
sections were stained with hematoxylin and eosin (H&E), according to the method 
described by Culling (1983). The slides were examined using a light microscope 
equipped with a digital camera (catalogue no. BA410E, Elite Biological Light 
Microscope, Motic, British Columbia, Canada).  
2.7 Feed composition analysis 
        To study the effect of CR and TC on feed composition, wet chemistry analysis 
was used, as previously described (Harris, 2010). Briefly, 1 kg of the CR or TC 
treatment feed was subjected to analysis for composition parameters included 
moisture (%), dry matter (%), crude protein (%), digestion energy (%), and essential 
mineral concentrations. The feed samples were analyzed at a commercial feed testing 
company (Dairy One Laboratory Services, Ithaca, NY). 
2.8 Statistical analysis  
        A completely randomized design was followed in the experiment. Broiler 
performance (BW, Feed intake, and FCR) data included 6 treatments, 10 
samples/treatment at each time point, and 4 time points (week 2, 3, 4, and 5). Organ 
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weight data (liver, spleen, and bursa of Fabricius) included 6 treatments, 10 
samples/treatment at each time point, and 4 time points (week 2, 3, 4, and 5). Feed 
composition data included 3 treatments (control, 0.75% CR, and 0.75% TC). PROC-
GENMOD procedure of the statistical analysis software (version 9.1, SAS Institute 
Inc. Cary, NC) was used. Differences among the means were detected at P < 0.05 
using Fisher’s Least Significance Difference (LSD) test with appropriate correction 
for multiple comparisons. 
3. Results  
3.1 Growth performance  
        No morbidity or mortality of birds due to AF ingestion was recorded in this study. 
The average BW of each experimental group is shown in Figure 1. In weeks 4 and 5, 
control birds had the maximum BW. Aflatoxin supplementation at 2.5 µg/g 
significantly reduced chicken BW in week 4 and week 5 by ~11% and ~18%, 
respectively as compared to control (P < 0.05). Although the results were not 
significant (P > 0.05), birds supplemented with TC at 0.75% were generally heavier 
than the AF-treated birds. However, in-feed supplementation of CR at 0.75% 
significantly increased the BW of the birds fed with 2.5 µg/g AF by ~ 13% as 
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compared to chickens fed with AF alone in week 5. However, feed intake and FCR 
were not significantly affected by the treatments. (Table 1)  
3.2 Relative organ weight  
        Table 2 shows the effect of CR and TC on the relative liver weight in chickens 
exposed to AF. Results indicated that the relative liver weight from AF-treated 
chickens was significantly greater in week 3 and week 5 as compared to the control (P 
< 0.05). In addition, in-feed supplementation of CR and TC significantly decreased 
the relative liver weight in birds compared to the AF-treated group (P < 0.05). 
Similarly, chickens fed with AF-contaminated feed demonstrated a significantly 
decreased relative bursa of Fabricius weight compared to other treatment groups 
(Table 3). No significant differences in relative bursa of Fabricius weight were 
observed among other treatment groups throughout the study. Relative spleen weights 
among the various treatment groups were not significantly different at any sampling 
point (P > 0.05, data not shown).  
3.3 Liver histologic analysis  
        Figure 2 shows the histologic analysis of liver from birds in week 3. Liver 
samples from control, 0.75% CR control, and 0.75% TC control revealed no 
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significant lesions and appeared normal (Fig. 2). Liver samples from AF-
supplemented chickens demonstrated moderate to severe hepatocellular degeneration, 
necrosis, and lymphoplasmacytic infiltration. However, the liver from birds fed with 
AF + CR or TC showed a lesser inflammatory infiltration and minimal hepatocellular 
degeneration and necrosis compared to the birds fed with AF alone (Fig. 2). No 
significant differences in the histologic analysis of liver among the treatment groups 
were observed in week 5 (data not shown).  
3.4 Feed composition  
        Feed composition analysis revealed no significant differences in moisture (%), 
dry matter (%), crude protein (%), acid detergent fiber (%), neutral detergent fiber (%), 
and the total energy (%) between control and phytochemical supplemented samples (P 
> 0.05). In addition, supplementation of CR or TC did not significantly affect the 
essential mineral content, including calcium (%), phosphorus (%), magnesium (%), 
potassium (%), sodium (%), manganese (µg/g), zinc (µg/g), copper (µg/g), iron (µg/g) 
(P > 0.05). 
4. Discussion  
        Aflatoxin contamination has been detected in poultry feed ingredients at pre- and 
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post-harvest, and after processing and packaging of feed ingredients (CAST, 1989). 
Ingestion of AF-contaminated feed results in chicken aflatoxicosis affecting bird 
health and performance. In addition, the adverse effects on public health due to the 
consumption of AF-contaminated poultry products constitute a significant hazard. The 
current study was designed at evaluating the efficacy of in-feed supplementation of 
CR and TC in reducing aflatoxicosis in broiler chickens.  
        Several studies have reported the adverse effects of AF on the performance of 
poultry, including BW (Dersjant-Li et al., 2003; Yunus et al., 2011). In the current 
study, we found a significant reduction in BW (when 2.5 µg/g AF diet was fed to 
broilers for 4 and 5 weeks) as compared to the control (Fig. 1), which is consistent 
with the study by Miazzo et al. (2000), who reported a 11% reduction in body weight 
gain at 2.5 µg/g of AF supplemented in the feed. However, we observed a reduction of 
BW due to AF exposure in birds only after 28 days of the experimental period (Table 
1 and Fig. 1). In addition, we did not observe any effect of AF on the feed intake and 
FCR in chickens, which concurred with the findings of Maizzo et al. (2000) and 
Pimpukdee et al. (2004) (Table 1). The effects of AF on feed intake and FCR are not 
always consistent because they depend on the composition of experimental diets, 
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particularly different protein sources and levels, which were reported to alter protein 
utilization and animal response to AF in poultry (Richardson et al., 1987; Coffey et al., 
1989).  
        The toxicity of AF is initiated through bioactivation to its toxic intermediates, 
which is mediated by cytochrome P450 enzymes located in the liver, thus making the 
liver the primary target for AF toxicity (Wogan, 1999; Wild and Turner, 2002). 
Furthermore, it has been documented that the negative effects of AF on chicken 
performance might be attributed to its harmful effects on liver weight and the liver 
function. In the current study, we observed a significantly increased relative liver 
weight in chickens fed with 2.5 µg/g AF as compared to the control group (Table 2). 
The enlarged liver may be due to the fatty infiltration and tissue proliferation (Eraslan 
et al., 2004; Shi et al., 2009) brought about by AF. In addition, it has been suggested 
that AF may generate a more profound toxicosis in modern broilers because of the 
rapid growth that requires faster hepatic metabolism (Yunus et al., 2011).  In line with 
these observations, histopathological analysis of the enlarged liver collected from the 
AF-treatment group revealed severe necrosis, bile duct proliferation, and 
hypertrophied liver cells as compared to the control. However, these lesions were 
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found to be alleviated in the liver samples from phytochemical-treated groups (Fig. 2). 
Thus, the findings from this study suggest the potential ability of CR and TC to 
counteract the harmful effects of AF, especially in reducing hepatic pathology changes 
induced by the toxin.  
        Apart from the toxicity of AF on the liver, the immunosuppressive nature of AF 
is another well-documented adverse effect on birds (Yunus et al., 2011). Aflatoxin 
consumption has been reported to cause vaccine failure (Mohiuddin and Reddy, 1993) 
due to AF-induced decrease in antibody titers against Newcastle disease vaccine 
(Mohiuddin and Reddy, 1993; Yunus et al., 2009) and decreased adaptive immunity 
(Ghosh et al., 1990). Verma et al. (2004) found a decreased relative weight of bursa of 
Fabricius from chickens fed with 2.0 µg/g AF. In the present study, results showed 
that the lymphoid organ, bursa of Fabricius of chickens given AF were markedly 
reduced in size, whereas CR and TC supplementation in the presence of AF 
significantly improved the relative bursa of Fabricius weight in week 4 when 
compared to AF-alone group (Table 3).  
        The mechanism of action of CR and TC against AF-induced toxicity is not yet 
documented. However, Ramirez et al. (2012) reported that CR was able to inhibit the 
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activity of P450 enzymes in vitro. Since the toxicity of AF is initiated from a complex 
metabolism by P450 enzymes in the liver, the reduced activity of P450 might be one 
of the potential protective mechanisms of phytochemicals to reduce aflatoxicosis in 
chickens. In addition, CR and TC are known to be potent antioxidants that can act as a 
scavenger of free radicals (Aeschbach et al., 1994; Gowder and Devaraj, 2006; Chen 
et al., 2009) and can influence the activities of enzymes that are associated with AF 
detoxification. For example, Gowder and Devaraj (2006) observed that the activity of 
glutathione S-transferase (GST) was significantly increased in rats that were orally 
given cinnamaldehyde for 90 days. The increase in the level of GST might potentially 
increase the detoxification of AF-related toxic intermediates during AF metabolism in 
the liver and increase the excretion of toxic AF intermediates through urine and bile 
(Essigmann et al., 1982; Wild and Turner, 2002). However, these findings need to be 
validated in chickens. 
        According to the results from wet chemistry analysis for feed composition, no 
differences were noticed between the control (basal diet) and the phytochemical-
supplemented feeds (P > 0.05) (Table 4), which supports the use of the 
phytochemicals as feed additives. Moreover, due to the lipophilic nature of CR and 
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TC, they can be easily mixed with other feed ingredients in a poultry ration. In 
conclusion, this study demonstrated that in-feed supplementation of CR and TC at 
0.75% reduced aflatoxicosis in chicken by improving bird performance and reducing 
AF-induced toxicity in liver. The results suggest that CR and TC could potentially be 
used as feed additives to control chicken aflatoxicosis; however, follow up studies 
under field conditions using a large of number of birds are warranted. 
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Table 1. Effect of in-feed supplementation of CR and TC on performance in chickens 
fed with 2.5 µg/g AF1. CR: carvacrol; TC: trans-cinnamaldehyde; AF: aflatoxins1,2. 
 
Body weight 
g/chicken 
Daily feed intake  
g/chicken 
Feed conversion ratio 
Treatments3 35d 0-35d 0-35d 
Control 3241a 148 1.42 
CR control 2818 c 136 1.52 
TC control 2902 bc 137 1.50 
AF 2650 d 131 1.52 
AF + CR 2987 c 130 1.37 
AF + TC 2789 cd 137 1.57 
SEM2 84 3 0.031 
a-d Means with different superscripts in a column differ significantly (P < 0.05). 
1Means represent 5 birds per pen and two pens per treatment. 
2Pooled standard error of the mean. 
3 Treatments include Control: feed with no AF and no CR/TC supplementation; CR 
control: 0.75% carvacrol control; TC control: 0.75% trans-cinnamaldehyde control; 
AF: 2.5 µg/g aflatoxins; AF+CR: 2.5 µg/g aflatoxins + 0.75% carvacrol; AF+TC: 2.5 
µg/g aflatoxins + 0.75% trans-cinnamaldehyde. 
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Table 2. Effect of in-feed supplementation of CR and TC on relative liver weight of 
chickens fed with 2.5 µg/g AF. CR: carvacrol; TC: trans-cinnamaldehyde; AF: 
aflatoxins1,2.  
 
Relative Liver Weight 
Items3 Week 2 Week 3 Week 4 Week 5 
CR 
    
Treatments 
    
Control 3.42% ± 0.71%a 2.50% ± 0.44% a 2.52% ± 0.34% a 2.44% ± 0.31% a 
CR control 3.45% ± 0.90%a 2.83% ± 0.48% ab 2.51% ± 0.21% a 2.35% ± 0.27% a 
AF 3.69% ± 0.41%a 3.04% ± 0.66% b 2.74% ± 0.30% a 2.73% ± 0.41% b 
AF + CR 3.79% ± 0.34%a 2.65% ± 0.31% ab 2.59% ± 0.28% a 2.40% ± 0.19% a 
TC 
    
Treatments 
    
Control 3.42% ± 0.71%a 2.50% ± 0.44% a 2.52% ± 0.34% ab 2.44% ± 0.31% a 
TC control 3.49% ± 0.50% a 2.54% ± 0.32% a 2.53% ± 0.23% ab 2.41% ± 0.35% a 
AF 3.69% ± 0.41%a 3.04% ± 0.66% b 2.74% ± 0.30% b 2.73% ± 0.41% b 
AF + TC 3.53% ± 0.55% a 2.56% ± 0.51% a 2.35% ± 0.40% a 2.38% ± 0.09% a 
a-b Means with different superscripts in a column differ significantly (P < 0.05). 
1Means represent 5 birds per pen and two pens per treatment. 
2Data are the mean ± SEM obtained from 5 birds per pen and two pens per treatment. 
Error bar indicates SEM (n=10/treatment). 
3 Treatments include Control: feed with no AF and no CR/TC supplementation; CR 
control: 0.75% carvacrol control; TC control: 0.75% trans-cinnamaldehyde control; 
AF: 2.5 µg/g aflatoxins; AF+CR: 2.5 µg/g aflatoxins + 0.75% carvacrol; AF+TC: 2.5 
µg/g aflatoxins + 0.75% trans-cinnamaldehyde. 
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Table 3. Effect of in-feed supplementation of CR and TC on relative bursa of 
Fabricius weight of chickens fed with 2.5 µg/g AF. CR: carvacrol; TC: trans-
cinnamaldehyde; AF: aflatoxins1,2.  
 
Relative Bursa of Fabricius Weight 
Items Week 2 Week 3 Week 4 Week 5 
CR 
    
Treatments 
    
Control 0.20% ± 0.09% a 0.20% ± 0.04% a 0.23% ± 0.06% a 0.19% ± 0.03% a 
CR control 0.16% ± 0.10% a 0.24 ± 0.09%% a 0.21% ± 0.04% a 0.17% ± 0.05% a 
AF 0.20% ± 0..06% a 0.19% ± 0.08% a 0.16% ± 0.03% b 0.13% ± 0.03% b 
AF + CR 0.17% ± 0.04% a 0.21% ± 0.03% a 0.21% ± 0.05% a 0.14% ± 0.02% b 
TC 
    
Treatments 
    
Control 0.20% ± 0.09% a 0.20% ± 0.04% a 0.23% ± 0.06% a 0.19% ± 0.03% a 
TC control 0.17% ± 0.04% a 0.19% ± 0.04% a 0.18% ± 0.03% a 0.18% ± 0.03% a 
AF 0.20% ± 0.06% a 0.19% ± 0.08% a 0.16% ± 0.03% b 0.13% ± 0.03% b 
AF + TC 0.18% ± 0.06% a 0.18% ± 0.05% a 0.20% ± 0.03% a 0.18% ± 0.04% a 
a-b Means with different superscripts in a column differ significantly (P < 0.05). 
1Means represent 5 birds per pen and two pens per treatment. 
2Data are the mean ± SEM obtained from 5 birds per pen and two pens per treatment. 
Error bar indicates SEM (n=10/treatment). 
3 Treatments include Control: feed with no AF and no CR/TC supplementation; CR 
control: 0.75% carvacrol control; TC control: 0.75% trans-cinnamaldehyde control; 
AF: 2.5 µg/g aflatoxins; AF+CR: 2.5 µg/g aflatoxins + 0.75% carvacrol; AF+TC: 2.5 
µg/g aflatoxins + 0.75% trans-cinnamaldehyde. 
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Table 4. Effect of carvacrol (CR) and trans-cinnamaldehyde (TC) supplementation on 
feed composition. 
 Control1  0.75% CR2 0.75% TC3 
Moisture % 9.8 9.9 11.6 
Dry Matter % 90.3 90.2 88.4 
Crude Protein % 17.8 17.4 17.6 
Acid Detergent Fiber %  10.7 10 9 
Neutral Detergent Fiber % 26.3 22.2 23.2 
Total Digestible Energy %  70 71 69 
Calcium, % 0.93 0.92 0.88 
Phosphorus, % 0.83 0.81 0.78 
Magnesium, % 0.3 0.29 0.29 
Potassium, % 0.78 0.75 0.7 
Sodium, % 0.143 0.138 0.149 
Manganese, µg/g 194 192 186 
Zinc, µg/g 213 214 206 
Copper, µg/g 26 25 21 
Iron, µg/g 231 223 231 
1 Control: no CR/TC supplementation 
20.75% CR: 0.75% carvacrol 
30.75% TC: 0.75% trans-cinnamaldehyde 
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Figure 1. Effect of in-feed supplementation of CR and TC on body weight of 
chickens fed with 2.5 µg/g AF. Control: feed with no AF and no CR/TC 
supplementation; CR control: 0.75% carvacrol control; TC control: 0.75% trans-
cinnamaldehyde control; AF: 2.5 µg/g aflatoxins; AF+CR: 2.5 µg/g aflatoxins + 
0.75% carvacrol; AF+TC: 2.5 µg/g aflatoxins + 0.75% trans-cinnamaldehyde. Data 
are the mean ± SEM obtained from 5 birds per pen and two pens per treatment. Error 
bar indicates SEM (n=10). a-c indicates means with different superscripts differ 
significantly (P < 0.05) 
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Figure 2. Effect of in-feed supplementation of CR and TC on liver histopathology in 
chickens fed with 2.5 µg/g AF in week 3. (A) Control: feed with no AF and no CR/TC 
supplementation [hematoxylin and eosin (H and E) stain, × 100]; (B) CR control: 
0.75% carvacrol control (H and E stain, × 100); (C) TC control: 0.75% trans-
cinnamaldehyde control (H and E stain, × 200); (D) AF: 2.5 µg/g aflatoxins (H and E 
stain, × 100); (E) AF+CR: 2.5 µg/g aflatoxins + 0.75% carvacrol (H and E stain, × 
100); (F) AF+TC: 2.5 µg/g aflatoxins + 0.75% trans-cinnamaldehyde (H and E stain, 
× 200). 
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Chapter VI 
Effect of in-feed supplementation of phytochemicals on the hepatic 
transcriptome of broiler chickens exposed to aflatoxin 
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ABSTRACT 
Aflatoxins (AF) are hepatotoxic metabolites produced by Aspergillus flavus and 
Aspergillus parasiticus, which frequently contaminate poultry feed ingredients. 
Contamination of poultry feed with AF is a major concern to the poultry industry, 
since aflatoxicosis in chickens results in significant economic losses due to decreased 
chicken performance and increased mortality. Our previous research revealed that in-
feed supplementation of two GRAS (generally recognized as safe)-status 
phytochemicals, namely carvacrol (CR) and trans-cinnamaldehyde (TC), significantly 
reduced aflatoxicosis in broiler chickens and decreased AF-induced toxic effect in 
chicken liver. In this study, we investigated the effect of in-feed supplementation of 
CR and TC on the hepatic transcriptome of chickens exposed to AF. Chicken livers 
were collected from birds fed with AF contaminated feed (~2.5 ppm) with or without 
supplementation of 0.75% CR or TC for 3 weeks. Whole transcriptome profile of 
liver samples from control and treated chickens were analyzed using RNA-seq on 
Illumina NextSeq 500 platform. Briefly, total RNA was extracted from chicken liver 
(5 liver samples/ group), and RNA-seq libraries were created and run on four flow 
cell lanes to produce over 340 million paired-reads totaling 36.8 Gb of sequence. 
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Approximately, 29,181 predicated transcripts were mapped to the reference chicken 
genome, of which 548 genes had significant differential expression in at least one 
pair-wise comparison between control and treatment groups. Results revealed that 
pathways and genes that are associated with hepatic diseases and lipid metabolism 
were affected by AF diet compared to control; however, supplementation of CR and 
TC to AF diet modulated genes involved in these pathways. Genes identified through 
transcriptome analysis provide candidates for further study of aflatoxicosis in 
chickens, and elucidate the potential protective mechanisms to liver mediated by CR 
and TC from aflatoxicosis in chickens. 
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1. Introduction  
        Aflatoxins (AF), a group of fungal toxic metabolites of Aspergillus flavus and 
Aspergillus parasiticus, are common contaminants of poultry feed (Oguz et al., 2000; 
Sur and Celik, 2003). Aflatoxicosis in chickens causes significant economic losses to 
the poultry industry due to poor feed utilization, decreased body weight gain, reduced 
egg production and increased mortality (Qureshi et al., 1998; Tessari et al., 2006; 
Oguz, 2011). Aflatoxicosis is estimated to cost the poultry industry over $143 million 
in economic losses each year (CAST, 1989). Once ingested by chickens, AF can 
accumulate in most of the soft tissues and fat depots of birds resulting in hemorrhagic 
and enlarged liver (Leeson et al., 1995; Bintvihok et al, 2002). Aflatoxin B1 (AFB1) is 
one of the most potent hepatocarcinogens, and the toxicity of AFB1 is initiated by its 
active metabolite, AF-8, 9-epoxide, which is metabolized by several P450 cytochrome 
(CYP) enzymes in liver. This active metabolite binds to proteins and forms adducts 
such as AFB1-lysine in albumin, besides binding to guanine residues in DNA and 
forming guanyl-N7 adducts initiating the formation of hepatocarcinomas (Hsu et al., 
1991). Due to its carcinogenic properties, AFB1 has been listed as a group I human 
carcinogen by the International Agency for Research on Cancer (Yunus et al., 2011). 
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Thus, it is critical to control AF in poultry feed to protect public health, bird health, 
and to ensure the economic viability of the poultry industry. Our previous research 
revealed that in-feed supplementation of two GRAS (generally recognized as safe)-
status phytochemicals, namely carvacrol (CR) and trans-cinnamaldehyde (TC), 
effectively reduced aflatoxicosis in broiler chickens, where a decreased AF-induced 
toxic effect in liver was observed (Yin et al., 2015b). Carvacrol (CR) is a major 
component in oregano oil obtained from Origanum vulgare (Lamiaceae), a common 
herb found in Europe and the Mediterranean. Carvacrol has been documented to exert 
antimicrobial activity against a wide range of microorganisms (Upadhyay et al., 2014). 
Trans-cinnamaldehyde (TC), on the other hand, is a GRAS-status ingredient present 
in the bark extract of cinnamon (Cinnamomum zeylandicum). Various studies have 
demonstrated the antimicrobial properties of TC against both gram-negative and -
positive bacteria (Burt, 2004; Upadhyay et al., 2014). 
        Hepatic transcriptome studies using RNA-sequencing (RNA-Seq) in turkeys and 
ducklings exposed to AFB1 have revealed differential expression in genes associated 
with fatty acid, energy metabolism, detoxification, development, immunity, cell 
proliferation, and cancer upon AF exposure (Yarru et al., 2009; Monson et al., 2014; 
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Zhang et al., 2016). However, systematic and functional analysis of the hepatic 
transcriptome in broiler chickens exposed to AF has not been reported. Therefore, the 
objective of this study was to discover the altered response of the hepatic 
transcriptome of chickens exposed to AF using high throughput RNA-seq. In addition, 
to elucidate the potential mechanisms by which CR and TC protect liver from 
aflatoxicosis in chickens, we determined the effect of in-feed supplementation of 
these phytochemicals on the response of hepatic transcriptome to AF in broiler 
chickens.  
2. Materials and Methods  
2.1 Animal samples 
        All experiments were approved by the Institutional Animal Care and Use 
Committee (IACUC) at the University of Connecticut. Day-old broiler chicks (Ross x 
Ross) were obtained from a commercial hatchery and randomly assigned to floor pens 
provided with ad libitum feed, water, age-appropriate ambient temperatures, and 
bedding at the Poultry Isolation Facility of the University of Connecticut.  
A total of 240 chickens were randomly assigned to 6 different treatments with 20 
birds per pen and two pens per treatment. The 6 treatment groups included: (1) 
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Control (feed with no AF and no CR/TC supplementation), (2) CR control (feed with 
no AF, but 0.75% supplemental CR), (3) TC control (feed with no AF, but 0.75% 
supplemental TC), (4) AF (feed containing ~2.5 ppm AF), (5) AF+CR (feed 
containing ~2.5 ppm AF and 0.75% supplemental CR), and (6) AF+TC (feed 
containing ~2.5 ppm AF and 0.75% supplemental TC). 
2.2 RNA isolation and sequencing  
On week 3 of the experiment, liver samples of five chickens from each treatment 
group were subjected to transcriptome analysis. Total RNA was isolated from each 
chicken liver sample by TRIzol extraction (Ambion, Inc., Austin, TX, USA), followed 
by DNAase-treatment (Turbo DNA-free kit, Ambion Inc., Austin, TX, USA), and the 
samples were stored at -80oC. Spectrophotometry (Nanodrop 1000, Nanodrop 
Technologies, Wilmington, DE, USA) was used for an initial assessment of RNA 
concentration and quality. The RNA integrity of the samples was confirmed using 
2100 Bioanalyzer (Agilent Technologist, Santa Clara, CA, USA), and only samples 
that had an RNA integrity score (RIN) of above 7.0 was used for subsequent analyses. 
All RNA samples had clear separation of 18S and 28S peaks on the 
electropherograms. RNA samples (N=30; 5 samples per treatment) were submitted to 
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University of Connecticut Center for Genome Innovation (UConn CGI) for library 
preparation and sequencing. Indexed libraries were constructed with 1 µg of total 
RNA/sample with the TruSeq RNA Sample Preparation Kit version 2 (Illumina Inc., 
San Diego, CA, USA). The libraries were multiplexed and sequenced on four flow 
cell lanes on the NextSeg 500 (Illumina Inc., San Diego, CA, USA) to produce 2 x 75 
bp paired-end reads.  
2.3 Read trimming, dataset QC analysis, and mapping  
        For dataset trimming, sequences with low quality, containing adaptor sequences, 
and less than 30 nucleotides were removed for further analysis. The quality of each 
dataset before and after trimming was measured with FastQC program. The corrected 
reads were aligned to a chicken reference genome using STAR aligner 
genomeGenerate mode and the mapped reads were converted to read counts using 
htseq-count (Gao et al., 2016). 
2.4 Differential expression and functional analysis 
        The expression of each transcript in each treatment group was determined using 
the R package DESeq2 following the standard workflow (Love et al., 2014). Read 
counts were first fit to a model based on a negative binomial distribution and 
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normalized by size-scaling for differences in library sequencing depth. Empirical 
Bayes shrinkage estimates of dispersion and log2 fold change (log2FC) were 
employed by DESeq2 to prevent over-dispersion, equalize the dynamic range of read 
counts, handle variable sample sizes, and make log2FC reproducible. Differential 
expression (DE) of genes between groups was then evaluated using normalized read 
counts. Transcripts were considered to possess statistically significant DE if q-value 
(FDR adjusted p-value based on the Benjamin-Hochberg procedure) was ≤ 0.05. 
Expression in each treatment (CR control, TC control, AF, AF+CR, AF+TC) was 
compared to control group to determine the impact of AF and/or phytochemicals. In 
addition, AF+CR and AF+TC groups were also individually compared to the AF 
group to determine the effect of CR and TC supplementation on chicken liver in the 
presence of AF.  
      Principle component analysis (PCA) plots, MA plots, and heatmaps were created 
in R studio by DESeq2 to visualize the expression data and the results of significance 
testing, as previously described (Monson et al., 2014; Monson et al., 2015). For all 
significant DE transcripts in each pair-wise comparison, gene pathways and 
toxicological functions were investigated using Ingenuity Pathway Analysis (IPA) 
 148 
(Ingenuity Systems, Redwood City, CA, USA).  
3. Results  
3.1 RNA-seq dataset 
        Total RNA isolated from chicken livers treated with or without AF in the 
presence or absence of CR or TC (n=5/ treatment) was used for the construction of 
individual barcoded libraries. RNA-seq libraries (30 libraries) were sequenced to 
produce over 340 M paired reads (681 M total reads) totaling 36.8 Gb of raw 
sequence data (Table 1). After mapping, one sample from AF group and one sample 
from TC control group showed only 39% and 32% of uniquely mapped ratio to the 
chicken reference, and 60.33% and 66.56% of the sequences were unmapped. 
Therefore, these two samples were excluded for subsequent analyses. Approximately 
79.9% of corrected sequence mapped uniquely to the annotate chicken gene set using 
STAR aligner (Table 2). The percentage of genomic alignment was similar among the 
groups (Control 84.9% ± 0.9; CR control 83.1% ± 1.7; TC control 82.1% ± 2.7; AF 
76.6% ± 2.5; AF+CR 75.9% ± 3.4; AF+TC 77.2% ± 4.7; mean ± SEM), thereby 
suggesting that there were no obvious detectable biases in the sequence data.  
3.2 Sample variation  
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        Principle Component Analysis (PCA) was used to evaluate variations within and 
between groups based on regularized log2 transformed read counts (Figure 1). The 
principle component 1 (PC1) axis explained the greatest amount of the variation (39%) 
and separated transcriptomic expression profiles between TC control and AF+TC. 
Similarly, principle component 2 (PC2) axis indicated a 25% variance. Overall, this 
distribution illustrates the difference between 6 treatment groups.  
3.3 Differential expression (DE) analysis  
        When the treatment groups AF, AF+CR, and CR control were separately 
compared to the control (AF/Control, AF+CR/Control, CR control/Control) using 
DESeq2 package, a total of 507 genes were found to be significantly affected, 
including 246 genes that were significantly up-regulated and 261 down-regulated 
genes (Figure 2). Specifically, 185 genes were regulated (72 up-regulated and 113 
down-regulated) by AF-treated group as compared to the control (AF/Control), and 
348 genes (178 up-regulated and 170 down-regulated) were found to be affected in 
AF+CR when compared to the control (AF+CR/Control). Three genes were in 
common in these three groups (AF, AF+CR, and CR control), and AF/Control and 
AF+CR/Control shared a total of 60 genes. Similarly, when the treatment groups AF, 
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AF+TC, and TC control were compared to the control (AF/Control, AF+TC/Control, 
and TC control/Control), respectively, expressions of 678 genes were found to be 
significantly changed, of which 344 genes were up-regulated and 334 genes were 
down-regulated. In addition, 548 genes (280 up-regulated and 268 down-regulated) 
were significantly regulated in AF+TC/Control. Six genes were in common within 
these 3 groups (AF/Control, AF+TC/Control, and TC control/Control), and 72 genes 
were in common between AF/Control and AF+TC/Control.  
        Furthermore, we compared significant DE of AF+CR group to CR control group 
(AF+CR/CR control) and AF+TC group to TC control group (AF+TC/TC control). 
Results revealed that 130 genes were significantly up-regulated and 114 genes were 
significantly down-regulated in AF+CR/CR control comparison. Likely, 260 genes 
and 168 genes were found to be significantly up- and down- regulated AF+TC/TC 
control. In addition, 15 genes were in common between AF+CR/AF and AF+CR/CR 
control, and 118 genes were in common between AF+TC/AF and AF+TC/TC control 
(Figure 3).  
        To visualize the distribution of the significant DE, log2 fold change was plotted 
against mean normalized expression for each predicated transcript by comparing AF 
 151 
to control, AF+CR to AF, and AF+TC to AF (Figure 4). In addition, relative similarity 
between the six treatment groups was expressed in the Heatmap (Figure 5). When the 
top 1000 transcripts with highest expression level in each treatment were compared, 
CR control and control groups were clustered and TC control group had the furthest 
distance to control. 
3.4 Functional analysis  
3.4.1 Impact of AF 
        In the AF group, 38.9% of significant DE transcripts were up-regulated and 
61.1% of significant DE transcripts were down-regulated when compared to control 
(AF/Control). These significant DE transcripts in the AF group are involved in the 
pathways associated with metabolism of lipid, hepatic diseases, inflammation of 
organs, and apoptosis (Table 3-6). Specifically, compared to the control, 17 genes 
associated with concentrations of lipids were regulated, including the up-regulation of 
genes PXRG, PPARGC1A, SMARCD3, ACSL1, CREB3L3, and AHSG. In addition, 14 
genes that are associated with the metabolism of lipids, including LSS, POR and 
HMGCR genes were down-regulated. These results suggest an increase in lipid 
accumulation and decrease in lipid metabolism in the AF-treated group as compared 
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to the control.  
        In addition, 8 genes related to hepatic steatosis, including STAT3, EHHADH, and 
LIPA genes were dysregulated in the AF/Control group. Moreover, 16 genes involved 
in hepatocellular carcinoma demonstrated 44% up-regulation and 56% down-
regulation, where up-regulation of RRM2 gene in the AF-treated group as compared to 
control has been used as a marker gene to identify hepatocellular carcinoma in 
humans (Looi et al., 2008; Wang et al., 2010). Additionally, 21 genes are related to 
inflammation of organs with 43% up-regulation and 57% down-regulation, and 11 
genes out of the 21 genes are specifically associated with inflammation of lung, 
including ABHD6, NBR1, HIF1A, and LIPA genes.  
        Apoptosis was also affected in the AF-treated group, where 29 genes with 
significant DE were down-regulated in AF group when compared to control. Since 
these genes are reported to decrease apoptosis, the down-regulation of these genes 
suggested an increase of apoptosis due to AF exposure.  
3.4.2 Effect of CR in the presence of AF 
        When we compared AF+CR group to the control (AF+CR/Control), 51% of the 
genes were up-regulated and 49% of the genes were down-regulated. Although 
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AF+CR/Control and AF/Control shared 60 genes (31 genes up-regulated and 29 genes 
down-regulated), no significant difference in the expression of these 60 genes was 
observed. Furthermore, we compared AF+CR group to AF group (AF+CR/AF) and 
results showed that 64% of genes with significant DE were up-regulated and 36% of 
genes were down-regulated. Out of these, four genes (GUCY2C, EPAS1, CAT, and 
ACAA2) associated with decreasing hepatic steatosis were up-regulated, indicating a 
decrease in hepatic steatosis in AF+CR when compared to AF-treated group (Table 7).   
3.4.3 Effect of TC in the presence of AF 
        The results of AF+TC/AF showed 33% up-regulation and 67% down-regulation 
of the genes with significant DE. Overall, 386 genes which had significant DE are 
associated with mobility and mortality, organismal death, thermoregulation, oxidation 
of fatty acids, and hepatic steatosis. Table 8 shows that 21 genes associated with 
hepatic steatosis had significant DE when compared AF+TC to AF (AF+TC/AF), and 
among these 14 up-regulated genes and 2 down-regulated genes demonstrated the 
potential to decrease hepatic steatosis. In addition, 14 genes were found to affect 
oxidation of fatty acids in AF+TC/AF, where 12 genes showed a trend to potentially 
increase the oxidation of fatty acids (Table 9). Moreover, 23 up-regulated genes 
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related to promote development are shown in Table 10 in AF+TC when compared to 
AF.  
3.4.4 Overall comparison  
        Differences in the pathways affected by AF and/or phytochemicals were also 
highlighted by comparative pathway analysis in IPA (Figure 6). For example, 
“LXR/PXR Activation” pathway was significant in AF, AF+CR, and AF+TC group, 
whereas levels of gene down-regulation were not similar in these three groups (33.3%, 
50%, and 100%, respectively). In addition, significant associations were made to the 
“Fatty Acid Metabolism” pathway in all 4 groups versus control except TC 
control/Control. In these comparisons (AF/Control, AF+CR/Control, AF+TC/Control 
and CR control/Control), AF/Control had the highest ratio of down-regulation of the 
genes (71%) in the “Fatty Acid Metabolism” pathway, followed by AF+CR/Control 
(33%) and AF+TC/Control (33%). Moreover, “Increases Liver Hyperplasia/ 
Hyperproliferation” and “p53 Signaling” pathways were significantly affected in 
AF/Control and AF+TC/Control, due to similar levels of down-regulation of genes in 
the pathway.  
4. Discussion 
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        Liver is the primary organ of AF accumulation and metabolism, and it is also the 
main site where AF metabolites bind with nucleic acids and proteins initiating its 
toxicity (Monson et al., 2014). Consequently, ingestion of AF-contaminated feed 
results in chicken aflatoxicosis affecting bird health and performance. Previously, we 
observed that feed containing 2.5 ppm AF produced phenotypic effects in chickens, 
including reduced chicken performance and enlarged relative weight of liver (Yin et 
al., 2015b). However, in-feed supplementation of CR or TC minimized the AF-
induced toxicity to chicken liver (Yin et al., 2015b). Therefore, in the present study, 
we utilized RNA-seq technique to characterize gene expression responses to AF in the 
hepatic transcriptome of broilers with or without in-feed supplementation of 
phytochemicals (CR and TC). 
4.1 Responses to AF 
        Intake of AF diet was hypothesized to result in gene expression changes in 
chicken liver representing characteristic pathophysiology associated with aflatoxicosis 
in chickens. RNA-seq results revealed that the expression of genes involved in some 
specific pathways, including hepatic diseases, lipid metabolism, inflammation of 
organs and apoptosis were altered in the hepatic transcriptome of chickens fed with 
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2.5 ppm AF diet for 3 weeks.  
        The carcinogenic nature of AF in mammals is well established and chronic 
exposure of AF constitutes a risk factor for hepatocellular carcinoma in humans 
(Monson et al., 2014). In chickens, acute and chronic aflatoxicosis cause lesions in 
liver, including bile duct proliferation/hyperplasia, fatty acid infiltration, and enlarged 
hepatic cells (Yunus et al., 2011; Yin et al., 2015a). Adverse effects on liver from AF 
exposure are likely caused by genes associated with cell cycle and apoptosis (Monson 
et al., 2014). In the current study, several genes associated with apoptosis were 
dysregulated. For instance, DHCR24 gene was down-regulated in AF-treated group 
when compared to the control. Since high expression of DHCR24 protects melanoma 
cells from apoptosis triggered by oxidative stress (Stasi et al., 2005), down-regulation 
of this gene potentially favors apoptosis.  
        Surprisingly, genes known to encode enzymes for phase I detoxification of AF in 
liver such as CYP3A4, CYP2A6, CYP1A1, and CYP1A2 were not significantly 
regulated in AF group as compared to control (AF/Control) in the current study. In 
mammals, CYP1A2 and CYP3A4 are capable of initiating the biotransformation of 
AFB1 into toxic intermediate AF-8, 9-epoxide, or other forms such as aflatoxin M1, 
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aflatoxin Q1, and other metabolites (Gallagher et al., 1996; Guengerich et al., 1996). 
Our results concurred with the findings of Zhang et al. (2016), who while analyzing 
the hepatic transcriptome of ducking liver under aflatoxicosis, observed that CYP 
genes were not affected upon AF exposure. Likewise, Monson et al. (2014) studied 
the hepatic transcriptome in turkeys exposed to AF and reported no expression 
changes of CYP1A5 and CYP3A37 in the AF-treated group. However, Yarru et al. 
(2009) by microarray analysis showed that CYP1A1 and CYP2H1, which are known 
to metabolize various xenobiotic metabolites, were up-regulated in chicken liver due 
to AF exposure (Yarru et al., 2009). Differences in the response of various poultry 
species such as chickens, turkeys, ducklings, and quails to AF exposure have been 
observed (Leeson et al., 1995; Diaz et al., 2010), and the biochemical basis for these 
differences has not been well understood. Although AF biotransformation in 
mammals is relatively well understood, in-depth studies in poultry are needed (Savlík 
et al., 2007). 
        In this study, DE analysis of the chicken liver transcriptome identified several 
genes associated with hepatocellular carcinoma in animals. For example, RRM2 gene, 
which was up-regulated in the AF group as compared to the control group, is linked to 
 158 
increased hepatocellular carcinoma. RRM2 is a subunit of ribonucleotide reductase 
that catalyzes the conversion of ribonucleotide 5’-diphoshphates into their 
corresponding 2’-deoxyribonucleotides. Satow et al. (2010) confirmed that the 
expression of RRM2 gene was increased in hepatocellular carcinoma patients and 
potentially accelerated the proliferation of the cancer cells.  
        Dietary AFB1 exposure in poultry has been known to induce changes lipid 
metabolism resulting in steatosis in the liver, which causes hepatomegaly and 
increased liver weight relative to body weight (Eaton and Gallagher, 1994; Bedard 
and Massey, 2006; Rawal and Coulombe, 2010). In addition, increased lipid content 
in liver due to AF exposure often causes liver pigmentation to become pale or yellow 
(Ortatatli and Oguz, 2001; Monson et al., 2015). In our study, multiple genes linked to 
hepatic steatosis and lipid metabolism were found to be significantly affected. For 
example, we observed a down-regulation of STAT3 genes, which potentially increase 
hepatic steatosis. Inoue and coworkers (2004) reported that liver-specific STAT3 
knockout increases hepatic triglyceride content in mouse and could eventually lead to 
fatty liver. In addition, LIPA gene encoding lysosomal acidic lipase (LPL) that 
hydrolyzes cholesteryl esters derived from cell internalization of plasma lipoproteins 
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was also down-regulated in the liver of birds fed with 2.5 ppm AF. LPL is involved in 
the breakdown of triglyceride in lipoproteins and is essential to lipid metabolism and 
storage (Ahn et al., 2011).  
        Significant DE was identified for multiple genes involved in lipid regulation. 
LSS, POR, HMGCR were significantly down-regulated in the AF group when 
compared to the control (AF/Control), which might alleviate the accumulation of fat 
vacuoles in liver. In addition, genes RXRG, PPARGC1A, SMARCD3, ACSL1, 
CREB3L3, and AHSG were up-regulated indicating elevated concentrations of 
acyglycerol, triacylglycerol, and lipids (Liu et al., 1999; Haugen et al., 2004; Lin et al., 
2004). The responses of these genes to AF exposure in chickens could be a response 
to the increased retention of lipids in the liver (Monson et al., 2014). Similar gene 
expression findings associated with fatty acid metabolism have been reported in 
ducklings and turkeys through RNA-seq technique (Monson et al., 2014 and Zhang et 
al., 2016). 
4.2 Impact of phytochemicals  
        Previously, we observed that CR and TC supplementation in AF-contaminated 
feed ameliorated AF-induced adverse effects in chickens (Yin et al., 2015b). 
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Histological analysis also revealed that phytochemicals reduced AF-induced toxic 
effects in the liver of birds fed with 2.5 ppm AF, where phytochemical-treated 
chickens had decreased hepatocellular degeneration, necrosis, and inflammation in the 
liver as compared to chickens fed with AF feed alone. In the present study, RNA-seq 
analysis demonstrated changes in gene expression in the liver of chicken fed with CR 
or TC and 2.5 ppm AF when compared to birds fed with AF alone. When we 
compared significant DE transcripts in the AF+CR group to AF group (AF+CR/AF), 
we observed a decrease of hepatic steatosis by up-regulating genes GUCY2C and 
EPAS1 in the AF+CR group. GUCY2C is a transmembrane receptor that makes cyclic 
guanosine monophosphate (cGMP) in response to paracrine hormones guanylin and 
uroguanylin. According to Valentino et al. (2011), silencing of GUCY2C in mice 
disrupts satiation, resulting in hyperphagia and subsequent obesity and metabolic 
syndrome. Moreover, Scortegagna and coworkers (2003) reported that mice lacking 
the HIF family member HIF-2-alpha encoded by EPAS1 show a syndrome of hepatic 
steatosis and dysregulated fatty acid oxidation.  
        Further, significant DE analysis comparing AF+TC and AF groups (AF+TC/AF) 
revealed that a total of 386 genes had significantly differed DE from the AF group, 
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and these genes are associated with hepatic steatosis, oxidation of fatty acids, 
development, organismal death, and thermoregulation. A total of 21 genes with 
significant DE in AF+TC group as compared to control were involved in hepatic 
steatosis. In addition, a substantial increase in expression was observed for LPIN1 
gene, which encodes Lipin1, which has been shown to regulate cellular lipid 
metabolism in liver (Finck et al., 2006). In the same study, Finck et al. (2006) also 
observed that mice that lacked Lipin1 demonstrated hepatic steatosis LPIN1 serves as 
a nuclear transcriptional co-activator in hepatocytes, where it interacts with a complex 
containing proliferator-activated receptors (PPARα and PPARγ) to regulate the 
expression of genes associated with fatty acid oxidation (Finck et al., 2006). In the 
current study, we observed an increase in the expression for PPAR receptors, 
PPARγ1α in AF+TC/AF, indicating an increase in fatty acid oxidation in chicken liver 
exposed to AF with TC supplementation. Additionally, multiple genes associated with 
development were found to be significantly up-regulated in AF+TC/Control, 
suggesting greater body size with TC supplementation in the presence of AF 
contamination. The phenotypic findings from our previous study also agree with the 
significant DE analysis that in-feed supplementation of TC with 2.5 ppm AF 
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increased body weight of birds when compared to birds fed with AF alone (Yin et al., 
2015b).  
5. Conclusions  
        In this study, hepatic transcriptome analysis using RNA-seq characterized 
pathways and genes associated with aflatoxicosis in chickens, including hepatic 
steatosis, hepatic carcinoma, fatty acid metabolism, inflammation, and apoptosis. In-
feed supplementation of CR and TC that phenotypically reduced AF-induced toxicity 
in chicken liver also showed a trend of decreased hepatic steatosis at the gene level by 
regulating the expression of associated genes when compared to AF. In addition, 
genes with significant DE in AF+TC group as compared to control suggested an 
increase in lipid oxidation and development. In summary, the current findings 
demonstrated the first comparison of the responses of chickens to AF with or without 
supplementation of phytochemicals, and delineated the potential mechanisms by 
which these phytochemicals reduced aflatoxicosis in chickens. However, further 
research on these major DE genes at the cellular level would be beneficial to validate 
the RNA-seq results. 
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Table 1. Summary of the RNA-seq datasets1. 
 
Total reads 
Total paired 
reads 
Total paired 
reads after 
trimming 
Total single reads 
after trimming 
Total discarded 
paired reads 
Total discarded 
single reads 
AF1 23040611.6 11520305.8 20065849.2 1373625.6 227511.2 1373625.6 
AF+CR2 22296719.2 11148359.6 19420677.6 1314987.4 246066.8 1314987.4 
AF+TC3 22912180 11456090 20412432.4 1159848 180051.6 1159848 
Control4 24870774.8 12435387.4 22707531.2 993746.4 175750.8 993746.4 
CR 
control5 
23678286.8 11839143.4 21261222.4 1121186.8 174690.8 1121186.8 
TC 
control6 
19403490.8 9701745.4 17463239.6 901513 137225.2 901513 
1 Treatments include Control: feed with no AF and no CR/TC supplementation; CR control: 0.75% 
carvacrol control; TC control: 0.75% trans-cinnamaldehyde control; AF: 2.5 ppm aflatoxins; 
AF+CR: 2.5 ppm aflatoxins + 0.75% carvacrol; AF+TC: 2.5 ppm aflatoxins + 0.75% trans-
cinnamaldehyde. 
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Table 2. Summary of the sequence mapping1. 
 Average input length Mapped reads Mapped (%) Unmapped (%) 
AF 145 7079017 76.575 22.1 
AF+CR 145 7462495 75.942 22.75 
AF+TC 146 7922860.8 77.242 21.596 
Control 146 9338607 82.112 16.444 
CR control 146. 8854640.6 83.112 15.406 
TC control 146 7755954.8 84.905 13.68 
1 Treatments include Control: feed with no AF and no CR/TC supplementation; CR control: 0.75% 
carvacrol control; TC control: 0.75% trans-cinnamaldehyde control; AF: 2.5 ppm aflatoxins; 
AF+CR: 2.5 ppm aflatoxins + 0.75% carvacrol; AF+TC: 2.5 ppm aflatoxins + 0.75% trans-
cinnamaldehyde. 
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Table 3. Differentially expressed genes associated with lipid metabolism in liver of 
chicken exposed to AF compared with control birds at the end of 21-d treatment 
period (AF/Control). 
Concentrations of Lipids 
Transcript ID Log2 FC1 Gene Symbol Gene Name 
ENSGALG00000003406 0.804 RXRG Retinoid X receptor gamma 
ENSGALG00000014398 0.781 PPARGC1A PPARG coactivator 1 alpha 
ENSGALG00000013049 0.601 SMARCD3 SWI/SNF related, matrix associated, actin dependent 
regulator of chromatin, subfamily d, member 3 
ENSGALG00000010628 0.587 ACSL1 Acyl-CoA synthetase long-chain family member 1 
ENSGALG00000001252 0.584 CREB3L3 cAMP responsive element binding protein 3 like 3 
ENSGALG00000008601 0.509 AHSG Alpha 2-HS glycoprotein 
ENSGALG00000008014 0.475 CEBPB CCAAT/enhancer binding protein beta 
ENSGALG00000003267 -0.391 STAT3 Signal transducer and activator of transcription 3 
ENSGALG00000011870 -0.573 HIF1A Hypoxia inducible factor 1 alpha subunit 
ENSGALG00000006378 -0.666 LIPA Lipase A, lysosomal acid type 
ENSGALG00000002053 -0.698 POR Cytochrome p450 oxidoreductase 
ENSGALG00000006211 -0.743 BCL2L1 BCL2 like 1 
ENSGALG00000015998 -0.777 PTDSS1 Phosphatidylserine synthase 1 
ENSGALG00000011801 0.705 ESR2 Estrogen receptor 2 
ENSGALG00000006680 -0.441 EHHADH Enoyl-CoA, hydratase/3-hydroxyacyl CoA dehydrogenase 
ENSGALG00000014948 -0.849 HMGCR 3-hydroxy-3-methylglutaryl-CoA reductase 
ENSGALG00000002747 -1.007 FASN Fatty acid synthase 
Metabolism of Lipids 
Transcript ID Log2 FC1 Gene Symbol Gene Name 
ENSGALG00000005696 1 ABHD6 Abhydrolase domain containing 6 
ENSGALG00000004106 -0.576 DHCR7 7-dehydrocholesterol reductase 
ENSGALG00000006198 -0.59 LSS Lanosterol synthase (2,3-oxidosqualene-lanosterol cyclase) 
ENSGALG00000009988 -0.626 ELOVL1 ELOVL fatty acid elongase 1 
ENSGALG00000006378 -0.666 LIPA Lipase A, lysosomal acid type 
ENSGALG00000002053 -0.698 POR Cytochrome p450 oxidoreductase 
ENSGALG00000015998 -0.777 PTDSS1 Phosphatidylserine synthase 1 
ENSGALG00000012834 -0.834 AKR1D1 Aldo-keto reductase family 1, member D1 
ENSGALG00000009365 -0.841 CYP51A1 Cytochrome P450 family 51 subfamily A member 1 
ENSGALG00000014948 -0.849 HMGCR 3-hydroxy-3-methylglutaryl-CoA reductase 
ENSGALG00000007493 -0.902 NSDHL NAD(P) dependent steroid dehydrogenase-like 
ENSGALG00000016331 -0.997 SQLE Squalene epoxidase 
ENSGALG00000002747 -1.007 FASN Fatty acid synthase 
ENSGALG00000010792 -1.114 AGMO Alkylglycerol monooxygenase 
ENSGALG00000010798 -1.266 DHCR24 24-dehydrocholesterol reductase 
1FC: fold change. 
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Table 4. Differentially expressed genes associated with hepatic diseases in liver of 
chicken exposed to AF compared with control birds at the end of 21-d treatment 
period (AF/Control). 
Hepatic steatosis 
Transcript ID Log2 FC1 Gene Symbol Gene Name 
ENSGALG00000014398 0.781 PPARGC1A PPARG coactivator 1 alpha 
ENSGALG00000010628 0.587 ACSL1 Acyl-CoA synthetase long-chain family member 1 
ENSGALG00000003267 -0.391 STAT3 Signal transducer and activator of transcription 3 
ENSGALG00000006680 -0.441 EHHADH Enoyl-CoA, hydratase/3-hydroxyacyl CoA dehydrogenase 
ENSGALG00000006378 -0.666 LIPA Lipase A, lysosomal acid type 
ENSGALG00000002053 -0.698 POR Cytochrome p450 oxidoreductase 
ENSGALG00000014948 -0.849 HMGCR 3-hydroxy-3-methylglutaryl-CoA reductase 
ENSGALG00000002747 -1.007 FASN Fatty acid synthase 
Hepatocellular carcinoma 
Transcript ID Log2 FC1 Gene Symbol Gene Name 
ENSGALG00000010469 0.998 CYP4A22 Cytochrome P450 family 4 subfamily A member 22 
ENSGALG00000016442 0.964 RRM2 Ribonucleotide reductase regulatory subunit M2 
ENSGALG00000014627 0.622 FRMD4B FERM domain containing 4B 
ENSGALG00000001252 0.584 CREB3L3 cAMP responsive element binding protein 3 like 3 
ENSGALG00000004477 0.564 NCOR1 Nuclear receptor corepressor 1 
ENSGALG00000021399 0.537 ABCA8 ATP binding cassette subfamily A member 8 
ENSGALG00000011811 0.511 SYNE2 Spectrin repeat containing nuclear envelope protein 2 
ENSGALG00000011870 -0.573 HIF1A Hypoxia inducible factor 1 alpha subunit 
ENSGALG00000001718 -0.646 CCNG1 Cyclin G1 
ENSGALG00000002053 -0.698 POR Cytochrome p450 oxidoreductase 
ENSGALG00000006211 -0.743 BCL2L1 BCL2 like 1 
ENSGALG00000012834 -0.834 AKR1D1 Aldo-keto reductase family 1, member D1 
ENSGALG00000008551 -0.847 CRELD2 Cysteine rich with EGF like domains 2 
ENSGALG00000003678 -0.896 GLUL Glutamate-ammonia ligase 
ENSGALG00000003879 -0.946 MFSD2A Major facilitator superfamily domain containing 2A 
ENSGALG00000016331 -0.997 SQLE Squalene epoxidase 
1FC: fold change. 
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Table 5. Differentially expressed genes associated with inflammation of organs in 
liver of chicken exposed to AF compared with control birds at the end of 21-d 
treatment period (AF/Control). 
Inflammation of organs 
Transcript ID Log2 FC1 Gene Symbol Gene Name 
ENSGALG00000005696 1 ABHD6 Abhydrolase domain containing 6 
ENSGALG00000016442 0.964 RRM2 Ribonucleotide reductase regulatory subunit M2 
ENSGALG00000003406 0.804 RXRG Retinoid X receptor gamma 
ENSGALG00000014398 0.781 PPARGC1A PPARG coactivator 1 alpha 
ENSGALG00000027907 0.648 NR2F1 Nuclear receptor subfamily 2 group F member 1 
ENSGALG00000014627 0.622 FRMD4B FERM domain containing 4B 
ENSGALG00000013992 0.54 VNN1 Vanin 1 
ENSGALG00000011811 0.511 SYNE2 Spectrin repeat containing nuclear envelope protein 2 
ENSGALG00000002765 0.401 NBR1 NBR1, autophagy cargo receptor 
ENSGALG00000003267 -0.391 STAT3 Signal transducer and activator of transcription 3 
ENSGALG00000009621 -0.428 ACTB Actin beta 
ENSGALG00000014971 -0.477 SLC2A9 Solute carrier family 2 member 9 
ENSGALG00000014140 -0.558 ARFGAP3 ADP ribosylation factor GTPase activating protein 3 
ENSGALG00000011870 -0.573 HIF1A Hypoxia inducible factor 1 alpha subunit 
ENSGALG00000006378 -0.666 LIPA Lipase A, lysosomal acid type 
ENSGALG00000002053 -0.698 POR Cytochrome p450 oxidoreductase 
ENSGALG00000001000 -0.723 HSPA5 Heat shock protein family A (Hsp70) member 5 
ENSGALG00000012834 -0.834 AKR1D1 Aldo-keto reductase family 1, member D1 
ENSGALG00000009365 -0.841 CYP51A1 Cytochrome P450 family 51 subfamily A member 1 
ENSGALG00000014948 -0.849 HMGCR 3-hydroxy-3-methylglutaryl-CoA reductase 
ENSGALG00000006211 -0.743 BCL2L1 BCL2 like 1 
1FC: fold change. 
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Table 6. Differentially expressed genes associated with cell apoptosis in liver of 
chicken exposed to AF compared with control birds at the end of 21-d treatment 
period (AF/Control). 
Apoptosis 
Transcript ID Log 2 FC1 Symbol Gene Name 
ENSGALG00000005622 -0.515 ARF4 ADP ribosylation factor 4 
ENSGALG00000006211 -0.743 BCL2L1 BCL2 like 1 
ENSGALG00000001718 -0.646 CCNG1 Cyclin G1 
ENSGALG00000010798 -1.266 DHCR24 24-dehydrocholesterol reductase 
ENSGALG00000010401 -0.47 EIF2A Eukaryotic translation initiation factor 2A 
ENSGALG00000028828 -0.48 EIF4E Eukaryotic translation initiation factor 4E 
ENSGALG00000001811 -0.581 EIF6 Eukaryotic translation initiation factor 6 
ENSGALG00000002747 -1.007 FASN Fatty acid synthase 
ENSGALG00000000947 -1.054 FKBP5 FK506 binding protein 5 
ENSGALG00000011870 -0.573 HIF1A Hypoxia inducible factor 1 alpha subunit 
ENSGALG00000012726 -0.752 HSP90B1 Heat shock protein 90 beta family member 1 
ENSGALG00000001000 -0.723 HSPA5 Heat shock protein family A (Hsp70) member 5 
ENSGALG00000017077 -0.964 HSPH1 Heat shock protein family H (Hsp110) member 1 
ENSGALG00000007659 -0.757 HYOU1 Hypoxia up-regulated 1 
ENSGALG00000027374 -1.119 KLF9 Kruppel like factor 9 
ENSGALG00000006378 -0.666 LIPA Lipase A, lysosomal acid type 
ENSGALG00000026900 -0.631 LYPLA1 Lysophospholipase I 
ENSGALG00000009782 -0.498 NAA15 N(alpha)-acetyltransferase 15, NatA auxiliary subunit 
ENSGALG00000021658 -0.65 PAFAH2 Platelet activating factor acetylhydrolase 2 
ENSGALG00000002053 -0.698 POR Cytochrome p450 oxidoreductase 
ENSGALG00000016162 -0.793 PTP4A3 Protein tyrosine phosphatase type IVA, member 3 
ENSGALG00000001435 -0.833 SDF2L1 Stromal cell derived factor 2 like 1 
ENSGALG00000004701 -0.361 SET SET nuclear proto-oncogene 
ENSGALG00000007251 -0.536 SIRT7 Sirtuin 7 
ENSGALG00000015916 -0.599 SLC17A5 Solute carrier family 17 m ember 5 
ENSGALG00000003267 -0.391 STAT3 Signal transducer and activator of transcription 3 
ENSGALG00000013837 -0.589 TBL1XR1 Transducin (beta)-like 1 X-linked receptor 1 
ENSGALG00000016651 -0.761 Tdh L-threonine dehydrogenase 
ENSGALG00000012585 -0.638 UBQLN1 Ubiquilin 1 
1FC: fold change. 
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Table 7. Differentially expressed genes associated with hepatic steatosis in liver of 
chicken exposed to AF with CR supplementation compared with birds fed with AF 
alone at the end of 21-d treatment period (AF+CR/AF).  
Hepatic steatosis 
Transcript ID Log2 FC1 Gene Symbol Gene Name 
ENSGALG00000011838 1.448 GUCY2C Guanylate Cyclase 2C 
ENSGALG00000010005 0.922 EPAS1 Endothelial PAS Domain Protein 1 
ENSGALG00000014471 0.856 CAT Catalase 
ENSGALG00000002777 0.567 ACAA2 Acetyl-CoA Acyltransferase 2 
1FC: fold change. 
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Table 8. Differentially expressed genes associated with hepatic steatosis in liver of 
chicken exposed to AF with TC supplementation compared with birds fed with AF 
alone at the end of 21-d treatment period (AF+TC/AF).  
Hepatic steatosis 
Transcript ID Log2 FC1 Gene Symbol Gene Name 
ENSGALG00000002159 0.770 ACOX1 Acyl-CoA Oxidase 1 
ENSGALG00000002479 0.636 MAT1A Methionine Adenosyltransferase 1A 
ENSGALG00000002891 0.461 ACADL Acyl-CoA Dehydrogenase 
ENSGALG00000003267 0.494 STAT3 Signal transducer and activator of transcription 3 
ENSGALG00000003579 0.874 INSR Insulin Receptor 
ENSGALG00000005992 1.067 PDE8A Phosphodiesterase 8A 
ENSGALG00000006534 1.315 PEX11A Peroxisomal Biogenesis Factor 11 Alpha 
ENSGALG00000006680 0.783 EHHADH Enoyl-CoA Hydratase And 3-Hydroxyacyl CoA 
Dehydrogenase 
ENSGALG00000007636 4.230 PCK1 Phosphoenolpyruvate Carboxykinase 1 
ENSGALG00000008202 0.680 NR1H3 Nuclear Receptor Subfamily 1 Group H Member 3 
ENSGALG00000011110 -1.349 DPP4 Dipeptidyl peptidase-4 
ENSGALG00000011558 1.158 LRP6 LDL Receptor Related Protein 6 
ENSGALG00000012437 1.828 IGFBP1 insulin-like growth factor-binding protein 1 
ENSGALG00000012748 -1.043 ELOVL2 ELOVL Fatty Acid Elongase 2 
ENSGALG00000014398 1.296 PPARGC1A PPARG Coactivator 1 Alpha 
ENSGALG00000016456 2.578 LPIN1 Lipin 1 
ENSGALG00000016839 1.638 IRS2 Insulin Receptor Substrate 2 
ENSGALG00000017394 1.254 INSIG1 Insulin Induced Gene 1 
ENSGALG00000023435 -1.652 GATM Glycine Amidinotransferase 
ENSGALG00000023806 1.429 PITPNA Phosphatidylinositol Transfer Protein Alpha 
ENSGALG00000026207 1.403 CNTF Ciliary Neurotrophic Factor 
1FC: fold change. 
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Table 9. Differentially expressed genes associated with oxidation of fatty acids in 
liver of chicken exposed to AF with TC supplementation compared with birds fed 
with AF alone at the end of 21-d treatment period (AF+TC/AF).  
Oxidation of Fatty Acids 
Transcript ID Log2 FC1 Gene Symbol Gene Name 
ENSGALG00000002159 0.770 ACOX1 Acyl-CoA Oxidase 1 
ENSGALG00000002891 0.461 ACADL Acyl-CoA Dehydrogenase 
ENSGALG00000003579 0.874 INSR Insulin Receptor 
ENSGALG00000006471 1.319 SLCO2A1 Solute Carrier Organic Anion Transporter Family 
Member 2A1 
ENSGALG00000006680 0.783 EHHADH Enoyl-CoA Hydratase And 3-Hydroxyacyl CoA 
Dehydrogenase 
ENSGALG00000007077 1.507 CPT1A Carnitine Palmitoyltransferase 1A 
ENSGALG00000009505 0.882 PNPLA8 Patatin Like Phospholipase Domain Containing 8 
ENSGALG00000009700 1.887 PDK4 Pyruvate Dehydrogenase Kinase 4 
ENSGALG00000010769 0.836 HPGD Hydroxyprostaglandin Dehydrogenase 15-(NAD) 
ENSGALG00000012809 0.676 ECI2 Enoyl-CoA Delta Isomerase 2 
ENSGALG00000013890 0.819 MC5R Melanocortin 5 Receptor 
ENSGALG00000014398 1.296 PPARGC1A PPARG Coactivator 1 Alpha 
ENSGALG00000016456 2.578 LPIN1 Lipin 1 
ENSGALG00000016839 1.638 IRS2 Insulin Receptor Substrate 2 
1FC: fold change. 
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Table 10. Differentially expressed genes associated with size of body in liver of 
chicken exposed to AF with TC supplementation compared with birds fed with AF 
alone at the end of 21-d treatment period (AF+TC/AF). 
Development  
Transcript ID Log2 FC1 Gene Symbol Gene Name 
ENSGALG00000000231 0.506 BNIP3L BCL2/Adenovirus E1B 19kDa Interacting Protein 3-Like 
ENSGALG00000002159 0.770 ACOX1 Acyl-CoA Oxidase 1 
ENSGALG00000003579 0.874 INSR Insulin Receptor 
ENSGALG00000003879 1.117 MFSD2A Major Facilitator Superfamily Domain Containing 2A 
ENSGALG00000004122 0.596 PNRC2 Proline Rich Nuclear Receptor Coactivator 2 
ENSGALG00000004288 1.251 HDAC4 Histone Deacetylase 4 
ENSGALG00000004460 0.725 FOXK1 Forkhead Box K1 
ENSGALG00000005095 1.853 SLC25A25 Solute Carrier Family 25 Member 25 
ENSGALG00000005332 1.411 CACNA1D Calcium Voltage-Gated Channel Subunit Alpha1 D 
ENSGALG00000005541 0.952 GJB1 Gap Junction Protein Beta 1 
ENSGALG00000005553 0.998 NLGN3 Neuroligin 3 
ENSGALG00000007636 4.230 PCK1 Phosphoenolpyruvate Carboxykinase 1 
ENSGALG00000007870 0.817 SMAD3 SMAD Family Member 3 
ENSGALG00000008097 0.907 Celf1 Elav-Like Family Member 1 
ENSGALG00000008701 1.681 XDH Xanthine Dehydrogenase 
ENSGALG00000009505 0.882 PNPLA8 Patatin Like Phospholipase Domain Containing 8 
ENSGALG00000013867 1.724 PTPN2 Protein Tyrosine Phosphatase, Non-Receptor Type 2 
ENSGALG00000014398 1.296 PPARGC1A PPARG Coactivator 1 Alpha 
ENSGALG00000015472 0.772 CHD7 Chromodomain Helicase DNA Binding Protein 7 
ENSGALG00000015775 1.419 UBE2J1 Ubiquitin Conjugating Enzyme E2 J1 
ENSGALG00000016839 1.638 IRS2 Insulin Receptor Substrate 2 
ENSGALG00000017394 1.254 INSIG1 Insulin Induced Gene 1 
ENSGALG00000023806 1.429 PITPNA Phosphatidylinositol Transfer Protein Alpha 
1FC: fold change. 
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Figure 1. Principle component analysis (PCA). PCA was performed on regularized 
log2 transformed read counts in DESeq2. Principle component 1 (PC1) and principle 
component 2 (PC2) explain 64% of the variation in read counts. Samples are plotted 
by group: AF (aflatoxin; red), AF+CR (aflatoxin + carvacrol; brown), AF+TC 
(aflatoxin + trans-cinnamaldehyde; green), Control (light blue), CR control (carvacrol 
control; dark blue), TC control (trans-cinnamaldehyde control; pink). 
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Figure 2. Liver transcripts with significant differential expression (DE) in each 
comparison between treatment groups. Numbers in each section indicate predicted 
transcripts with significant DE (q value < 0.05) that are shared between or unique to 
each comparison. ↑ indicates the up-regulated transcripts and ↓ indicates down-
regulated transcripts. The total number of significant transcripts for each comparison 
is shown beside the corresponding circle. This figure shows transcripts with 
significant DE when compared to the control group.  
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Figure 3. Liver transcripts with significant differential expression (DE) in each inter-
treatment comparison. Numbers in each section indicate predicted transcripts with 
significant DE (q value < 0.05) that are shared between or unique to each comparison. 
↑ indicates the up-regulated transcripts and ↓ indicates down-regulated transcripts. 
This figure shows transcripts with significant DE in inter-treatment comparisons 
(AF+CR/AF: Compared AF+CR group to AF group; AF+CR/CR control: Compared 
AF+CR group to CR control group; AF+TC/AF: Compared AF+TC group to AF 
group; AF+TC/TC control: Compared AF+TC group to TC control group) 
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Figure 4. Relationship between mean expression and log2 fold change in each 
comparison between treatment groups. Log2 fold change was plotted against the mean 
normalized read counts for each predicted transcript with non-zero expression values 
in each comparison between treatment groups. As determined in DESeq2, transcripts 
with significant differential expression (DE) are highlighted in red (q-values < 0.05). 
(4A) AF/Control; Compared AF group to the control (4B) AF+CR/AF; Compared 
AF+CR group to AF (4C) AF+TC/AF; Compared AF+TC group to AF.  
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Figure 5. Comparative expression of selected transcripts across all six treatment 
groups. Heatmap was generated from variance stabilized and normalized read counts 
using DESeq2 across aflatoxin (AF), aflatoxin + carvacrol (AF+CR), aflatoxin + 
trans-cinnamaldehyde (AF+TC), control, carvacrol control (CR control), and trans-
cinnamaldehyde control (TC control). 
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Figure 6. Significant pathways associations vary in comparison of each treatment to 
control. In each pair-wise comparison, Ingenuity Pathway Analysis (IPA) assigned p-
values to canonical pathways based on differential expression (DE). Bar plot provides 
5 example pathways with variable significance between the AF (aflatoxin group; dark 
blue), AF+CR (aflatoxin + carvacrol; bright blue), AF+TC (aflatoxin + trans-
cinnamaldehyde; light blue), CR control (carvacrol control; black) and TC control 
(trans-cinnamaldehyde control; grey). Pathway associations must have a –log(p-value) 
> 1.3 (threshold, vertical yellow line) to be considered significant.   
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        Mycotoxins are toxic secondary metabolites that are capable of causing disease 
and death in both animals and humans. The Food and Agriculture Organization (FAO) 
reported that 25% of the world’s grains are contaminated by mycotoxins; aflatoxin 
(AF) contamination is the most common among them. Aflatoxins (AF) are toxic, 
mutagenic, and carcinogenic compounds produced by molds, Aspergillus flavus and 
Aspergillus parasiticus, which can frequently contaminate feed ingredients such as 
peanuts, corn, and cottonseed and cause aflatoxicosis in animals and humans.  
        Aflatoxicosis in poultry due to ingestion of AF contaminated feed negatively 
affects chicken production parameters, causing severe economic losses to the poultry 
industry. Specifically, dietary exposure to AF leads to decreased body weight, feed 
intake, and efficiency of nutrient usage. In addition, AF residues in poultry products 
pose a significant health hazard to humans. Thus, it is critical to develop scientifically 
validated strategies for controlling AF in poultry feed and aflatoxicosis in chickens to 
protect public health, bird health, and to ensure the financial sustainability of the 
poultry industry. 
        This dissertation investigated the efficacy of two natural plant-derived 
antimicrobials, namely carvacrol (CR) and trans-cinnamaldehyde (TC), for 
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controlling aflatoxicosis in chickens. The first objective investigated the effect of CR 
and TC on A. flavus and A. parasiticus growth, AF production, and expression of 
toxin production genes in a broth system and in chicken feed during long-term storage. 
Results revealed that CR and TC significantly inhibited A. flavus and A. parasiticus 
growth and AF production in both broth system (P < 0.05) and in chicken feed during 
the entire storage period (P < 0.05). All the concentrations of CR and TC decreased 
AF concentrations in the feed to levels below the FDA regulated limit (20 ppb). 
However, feed samples with no added CR or TC yielded more than 30 ppb  of AF. In 
addition, CR and TC down-regulated the expression of major genes associated with 
AF synthesis in Aspergillus (P < 0.05). 
        During egg formation, AF residues could be transferred from the laying hen to 
the fertilized eggs, thereby resulting in decreased embryo viability and hatchability, 
and causing several organ malformations. Therefore, the second objective of this 
dissertation was to determine the efficacy of CR and TC in reducing AF-induced 
toxicity in chicken embryos. Results demonstrated that both phytochemicals 
significantly decreased AF-induced toxicity in chicken embryos. At 75 ng of AF/egg, 
CR and TC increased the survival of chicken embryo by ~ 55%. Moreover, CR and 
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TC significantly improved the growth of embryos (tibia length and weight) when 
compared to those injected with AF alone (P < 0.05).  
        Contamination of poultry feed with AF is a major concern to the poultry industry 
since aflatoxicosis in chickens results in significant economic losses due to poor feed 
utilization, decreased body weight, and increased mortality. Therefore, the third 
objective of this dissertation was to evaluate the efficacy of CR and TC as feed 
supplements in controlling aflatoxicosis in chickens. A total of 240 chickens were fed 
with AF contaminated feed (~2.5ppm) with or without supplementation of 0.75% CR 
or TC for 5 weeks. Results revealed that CR and TC supplementation in AF-
contaminated feed ameliorated AF-induced adverse effects in chickens. In addition, 
phytochemical supplementation significantly decreased relative liver weight and 
improved relative bursa of Fabricius weight in birds, as compared to AF-treated group 
(P < 0.05). Histologic analysis revealed that CR and TC reduced AF-induced toxic 
effects in the liver of birds, where phytochemical-treated chickens had decreased 
hepatocellular degeneration, necrosis and inflammation in the liver as compared to 
chickens fed with AF alone.  
        Liver is the primary organ for AF detoxification, but it also initiates the toxicity 
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of AF in the host. Among the 18 types of AF identified in feed, aflatoxin B1 (AFB1) is 
one of the most potent hepatocarcinogens, where its active metabolite, 8, 9, -epoxide, 
metabolized by P450 cytochrome in liver, binds to proteins and DNA and forms 
protein- and DNA- adducts initiating the formation of hepatocarcinomas. In the fourth 
objective of this dissertation, the effect of in-feed supplementation of CR and TC on 
the hepatic transcriptome of chickens exposed to AF eas studied. Chicken livers were 
collected from birds fed with AF contaminated feed (~2.5 ppm) with or without 
supplementation of 0.75% CR or TC, and whole transcriptome profile of liver 
samples from the control and treated chickens were analyzed using RNA-seq on 
Illumina NextSeq 500 platform. Results revealed that pathways and genes that are 
associated with hepatic diseases and lipid metabolism were affected by the AF diet 
compared to control; however, supplementation of CR and TC to the AF diet 
modulated several genes involved in these pathways.  
        To conclude, the results of this Ph.D. dissertation indicate that CR and TC could 
be potentially used as feed additives to control aflatoxicosis in chickens.  
